fbpx

ADVERTISEMENT

ADVERTISEMENT

enzalutamide

Brand Name :

Xtandi

Synonyms :

Class :

Antineoplastic agents & Antiandrogens





No data available for drug.

DRUG INTERACTION

enzalutamide

&

  • ibandronic acid
  • cinnarizine and dimenhydrinate
  • ursodeoxycholic acid
  • rhubarb extract/salicylic acid
  • butamirate citrate
  • fumitory
  • taheebo
  • uva ursi
  • vervain
  • coleus
  • coltsfoot
  • crampbark
  • plantain
  • potassium nitrate and silver nitrate
  • gelsemium
  • gentian
  • glucomannan
  • walnut
  • meadowsweet
  • midomafetamine
  • pennyroyal
  • periwinkle
  • betony
  • bitter orange
  • bladderwrack
  • bloodroot
  • emu oil
  • garcinia
  • yellow dock
  • burdock
  • dehydroepiandrosterone
  • aucubin
  • jasmone
  • resacetophenone
  • ecamsule ditriethanolamine
  • feclobuzone
  • fenoprop triethanolamine
  • verdyl acetate
  • caffeic acid
  • cyclamen aldehyde
  • dicetyldimonium chloride
  • wogonin
  • impacarzine
  • laurylpyridinium chloride
  • stepronin
  • matrine
  • sakuranin
  • cannabichromene
  • sandalore
  • sabinene
  • oxypaeoniflora
  • ethylhexyl pelargonate
  • acrylonitrile
  • allyl alcohol
  • dipalmitoylethyl hydroxyethylmonium methosulfate
  • butidrine
  • clothiapine
  • propanediol dicaprylate
  • buchu
  • undecanol
  • enilconazole
  • xymenynic acid
  • angelica
  • nizubaglustat
  • resomelagon
  • ulecaciclib
  • apple cider vinegar
  • bacopa
  • barley grass
  • dandelion
  • deer velvet
  • dolomite
  • bugleweed
  • bupleurum
  • glyceryltrinitrate
  • pociredir
  • asnuciclib
  • actalycabtagene autoleucel
  • butantan–dengue vaccine
  • travoprost/timolol
  • furosemide/potassium chloride
  • amylamine
  • jaborandi
  • patritumab deruxtecan
  • jackfruit
  • sterculia
  • ascorbigen
  • ashitaba
  • androstenetrione
  • andrachne
  • cosibelimab
  • racecadotril
  • neomycin/chlorhexidine
  • octocog alfa
  • cetrimide
  • ispaghula husk
  • polyhexanide
  • octenidine
  • polygeline
  • heparinoid
  • jewelweed
  • boldo
  • anizatrectinib
  • alpinia
  • henbane
  • cynanchum vincetoxicum root and sulfur
  • boditrectinib
  • izumerogant
  • zavondemstat
  • abuta
  • fadogia agrestis
  • fly agaric mushroom
  • meptazinol
  • methoxyflurane
  • tramadol/dexketoprofen
  • betaine/polyhexanide
  • filgotinib
  • inosine acedoben dimepranol
  • alverine citrate
  • hyoscine butylbromide
  • senna+ ispaghula
  • cabbage palm
  • cajeput oil
  • calanus oil
  • calamint
  • canada balsam
  • carnosine
  • alverine citrate/simeticone
  • dihydroartemisinin/piperaquine
  • mebeverine/ispaghula
  • calcipotriol
  • tacalcitol
  • triethyl citrate/ethyl linoleate
  • sodium dilauramidoglutamide lysine
  • fazamorexant
  • avibactam tomilopil and ceftibuten
  • drostanolone
  • tigilanol tiglate
  • isorhynchophylline
  • rhynchophylline
  • crisugabalin
  • epigallocatechin gallate
  • clomocycline
  • corynoxeine
  • isocorynoxeine
  • Culmerciclib
  • Neladenoson
  • ambrein
  • hexylcaine
  • phensuximide
  • resencatinib (investigational)
  • rolusafine
  • pumecitinib
  • arhalofenic acid
  • berdazimer sodium
  • benzquinamide
  • clidinium
  • sulfametopyrazine
  • fulzerasib (Investigational Drug)
  • rovadicitinib (Investigational Drug)
  • Upleganan (Investigational Drug)
  • menthyl ethylamido oxalate
  • quaternium-90 montmorillonite
  • unecritinib (investigational drug)
  • etohexadiol
  • guaiol
  • proximadiol
  • verdinexor
  • sofnobrutinib
  • talbutal
  • ethoxzolamide
  • propiomazine
  • enprofylline
  • phenmetrazine
  • merigolix
  • pralurbactam
  • neracorvir
  • vonifimod
  • apaziquone hydroquinone
  • darizmetinib
  • zandelisib
  • xininurad
  • ritivixibat
  • amiselimod phosphate (investigational drug)
  • emzeltrectinib (investigational drug)
  • ficonalkib
  • cinalukast
  • ulobetasol
  • candoxatril
  • nitrofural
  • acetyldigitoxin
  • bentiromide
  • dextrothyroxine
  • chlorotrianisene
  • remikiren
  • pipobroman
  • vidarabine
  • immune globulin intravenous, human-stwk
  • spermine
  • serine
  • N-acetyl glucosamine
  • valine
  • adenine
  • asparagine
  • citrulline
  • adinazolam
  • interferon alfacon-1
  • interferon alfa-n1
  • felypressin
  • birch triterpenes
  • pyridoxal phosphate
  • technetium Tc-99m arcitumomab
  • beta-alanine
  • dihomo-gamma-linolenic acid
  • urea/hydrocortisone
  • R21/Matrix-M vaccine
  • povidone-iodine (ophthalmic)
  • pheniramine
  • hydrocortisone rectal
  • chloroxylenol/pramoxine/zinc acetate
  • chloroxylenol/pramoxine
  • dextrose/sucrose/vitamin C/zinc sulphate
  • furazolidone/metronidazole/dicyclomine
  • ergocalciferol (vitamin D2)
  • benoxaprofen (discontinued)
  • teicoplanin
  • carbomer
  • chromic chloride / iron (ii) chloride tetrahydrate / potassium iodide / manganese chloride / sodium fluoride / sodium selenite pentahydrate / sodium molybdate dihydrate / zinc chloride/ cupric chloride
  • bufylline
  • lidocaine/prilocaine
  • opium tincture, squill oxymel
  • dibrompropamidine
  • metronidazole/tetracycline/bismuth subsalicylate
  • agnus- castus
  • velaglucerase alfa
  • alendronic acid / colecalciferol
  • bimatoprost / timolol
  • efbemalenograstim alfa
  • dried ferrous sulfate/folic acid
  • dried ferrous sulfate / sodium ascorbate
  • nirogacestat
  • soya-bean oil, medium-chain triglycerides
  • demeclocycline hydrochloride and triamcinolone acetonide
  • fusidic acid / hydrocortisone acetate
  • macrogol
  • storax, benzoin
  • nomegestrol acetate/estradiol
  • flumetasone pivalate/ clioquinol
  • berdazimer topical (Pending FDA Approval)
  • buflomedil
  • butobarbital
  • andexanet alfa
  • methoxypolyethylene glycol-epoetin beta
  • viscum abietis
  • pramoxine vaginal
  • bupivacaine implant
  • cromolyn sodium, inhaled
  • pneumococcal vaccine 20-valent
  • bimatoprost ophthalmic implant
  • tick-borne encephalitis vaccine
  • chloroprocaine ophthalmic
  • travoprost intraocular implant (Pending FDA approval)
  • typhoid polysaccharide vaccine
  • sodium phosphate rectal
  • human papillomavirus vaccine, nonavalent
  • peanut immunotherapy epicutaneous (FDA approval pending)
  • cromolyn sodium, intranasal
  • red blood cells(Blood component)
  • oral mucoadhesive
  • clindamycin vaginal
  • whole blood (Blood Component)
  • fibrinogen/thrombin
  • levothyroxine/liothyronine
  • ipratropium intranasal
  • metronidazole vaginal
  • cyamemazine
  • brinase
  • reviparin
  • ulinastatin
  • saruplase
  • acepromazine
  • emylcamate
  • methionine
  • amino acids and electrolytes in dextrose with calcium
  • slippery elm
  • camostat
  • hemoglobin crosfumaril
  • moperone
  • chlormidazole
  • brilaroxazine
  • palopegteriparatide
  • diazepam buccal
  • benegrastim (pending for FDA approval)
  • COVID-19 vaccine, adjuvanted-Novavax
  • vestronidase alfa-vjbk
  • tebipenem (Pending FDA Approval)
  • tislelizumab (Pending FDA Approval)
  • zolbetuximab (Pending FDA Approval)
  • zoliflodacin (pending FDA approval)
  • zibotentan and dapagliflozin
  • fluorine F18 DCFPyL
  • debamestrocel
  • givinostat
  • amubarvimab and romlusevimab(Pending FDA Approval)
  • sabizabulin(Pending FDA approval)
  • fexapotide(Phase 3 Clinical trial)
  • diatrizoic acid
  • drotaverine
  • diethyl phthalate
  • enclomiphene
  • epalrestat
  • ethamsylate
  • flupirtine
  • imidurea
  • sodium glycolate
  • feracrylum
  • ethacridine
  • furazolidone/metronidazole
  • ozagrel hydrochloride
  • leptazol
  • l-glutamic acid /vitamin B complex
  • etizolam
  • etizolam/propranolol
  • ethoheptazine citrate
  • etophylline and theophylline
  • etophylline
  • finger millet
  • drotaverine/mefenamic acid
  • dichloroxylenol
  • pneumococcal 7-valent vaccine
  • diclofenac and metaxalone
  • dipivefrin ophthalmic
  • enbucrilate
  • potassium citrate and citric acid
  • potassium gluconate
  • aclarubicin
  • alfuzosin/dutasteride
  • adrenochrome monosemicarbazone
  • selenium sulfide topical
  • sertaconazole
  • amorolfine cream
  • amsacrine
  • amylmetacresol
  • sulfonated phenolics in aqueous solution
  • technetium Tc-99m sulfur colloid
  • raltitrexed
  • romiplostim
  • acediasulfone
  • azulene
  • acebrophylline
  • clonazepam/escitalopram oxalate
  • allylestrenol
  • andrographolide
  • artemotil
  • technetium Tc-99m sestamibi
  • rubidium Rb-82
  • somapacitan
  • sodium sulfate, magnesium sulfate and potassium sulfate
  • almitrine
  • gramicidin
  • nikethamide
  • technetium Tc-99m sodium pertechnetate
  • betiatide
  • prilocaine/epinephrine
  • amlexanox
  • acetaminophen/salicylamide/phenyltoloxamine
  • neomycin topical
  • zilucoplan
  • antazoline and xylometazoline
  • toripalimab
  • iron isomaltoside
  • meningococcal A C Y and W polysaccharide tetanus toxoid conjugate vaccine
  • meningococcal A C Y and W-135 diphtheria conjugate vaccine
  • tetradecyl Sulfuric Acid
  • benzoyl peroxide, clindamycin phosphate, adapalene
  • ethylephedrine
  • actarit
  • pyrantel tartrate
  • tenofovir disoproxil fumarate or tenofovir DF
  • melitracen
  • amitriptylinoxide(Phase 4 Clinical Trials)
  • threonine
  • ditiocarb zinc
  • epicriptine
  • levallorphan
  • kinetin
  • laurocapram
  • pentagastrin
  • parthenolide
  • nicoboxil
  • protionamide
  • prulifloxacin
  • proscillaridin
  • tizanidine and rofecoxib
  • tolnaftate, gentamicin, chinoform and betamethasone valerate
  • pine bark extract
  • pipenzolate methylbromide
  • bephenium hydroxynaphthoate
  • niclosamide
  • pyrvinium
  • pipenzolate methylbromide/phenobarbitone
  • piracetam/ginkgo biloba/vinpocetine
  • benzyl benzoate/disulfiram
  • benzyl benzoate
  • loperamide/simethicone
  • piroctone olamine
  • sodium fusidate
  • piroxicam topical/capsaicin/menthol/methyl salicylate
  • sodium metabisulfite
  • sodium lauryl sulfate
  • taspoglutide
  • glyclopyramide
  • tolnaftate, gentamicin, iodochlorohydroxyquinoline, chlorocresol, betamethasone valerate
  • serratiopeptidase
  • sodium antimony gluconate
  • triamterene / benzthiazide
  • tribenoside / lidocaine
  • triclocarban
  • triprolidine/dextromethorphan  
  • vitamins/minerals/omega-3 Fatty acids
  • soyabean oil
  • sucralfate/oxethazaine
  • sucralfate/tinidazole/povidone iodine
  • sodium cromoglycate
  • aloe vera/liquid paraffin/white soft paraffin
  • aloe vera/jojoba oil/vitamin E
  • allantoin/triclosan/vitamin e/zinc oxide
  • alpha-Lipoic acid/minerals/multivitamins
  • alprazolam/paracetamol
  • alprazolam/melatonin
  • azithromycin/ambroxol
  • atorvastatin/clopidogrel/aspirin
  • aceclofenac, paracetamol and serratiopeptidase
  • alfacalcidol, vitamin B-complex, minerals and antioxidants
  • alpha- lipoic acid, vitamin b complex and vitamin c
  • alpha-galactosidase and simethicone
  • alpha-galactosidase, amylase, proteases, lipase and lactase
  • amikacin and cefepime
  • aminophylline, ephedrine and phenobarbitone
  • artesunate, sulphadoxine and pyrimethamine
  • finasteride/tamsulosin
  • flavoxate/ofloxacin
  • fenofibrate/metformin
  • lignocaine, hydrocortisone topical and allantoin
  • linoleic acid and sodium lactate
  • troxerutin
  • meclizine/nicotinic acid
  • mecobalamin/ginkgo Biloba
  • spirulina
  • loperamide and furazolidone
  • ketoconazole/cetrimide
  • ketoconazole/zinc pyrithione
  • lercanidipine/atenolol
  • levocetirizine/montelukast/ambroxol
  • levarterenol
  • levocetirizine/phenylpropanolamine 
  • indapamide/amlodipine
  • itopride/methyl polysiloxane
  • mebendazole/levamisole
  • eberconazole/mometasone
  • gliclazide/metformin/pioglitazone
  • fluconazole/tinidazole
  • haemocoagulase
  • halometasone
  • hesperidin
  • imipramine/chlordiazepoxide
  • idebenone / l-arginine / zinc sulphate/selenium/proanthocyanidin
  • mecobalamin and piracetam
  • mesterolone
  • mosapride and pantoprazole
  • atorvastatin, co enzyme q10, vitamin e, zinc, and selenium
  • azithromycin and benzalkonium chloride
  • beta carotene, vitamin c, vitamin e, minerals, lutein, eicosapentaenoic acid, docosahexenoic acid and vit b12
  • alpha-galactosidase
  • aloe vera gel/vitamin e/lactic acid
  • aloe vera gel/jojoba/vitamin e/glycerine
  • famotidine and domperidone
  • faropenem medoxomil
  • nedosiran
  • fluconazole/ornidazole/azithromycin
  • ebastine/montelukast
  • eberconazole
  • dienogest/estradiol valerate
  • ambroxol/salbutamol
  • benzoic acid/salicylic acid/ichthammol/ triamcinolone acetonide
  • desloratadine/ambroxol
  • dexibuprofen/paracetamol
  • atorvastatin/ramipril
  • diastase
  • diastase and simethicone
  • diazepam and propranolol
  • dexrabeprazole / domperidone
  • dexrabeprazole
  • dexketoprofen /paracetamol
  • beta carotene/vitamin C/minerals
  • aloe vera gel/urea
  • aloe vera gel/glycerine
  • alpha-lipoic acid/benfotiamine/chromium/folic acid/mecobalamin / vit b6
  • alprazolam/propranolol
  • alprazolam /sertraline
  • ibuprofen/dextropropoxyphene
  • ambroxol/cetirizine/phenylephrine/ guaiphenesin/menthol
  • dextropropoxyphene/dexchlorpheniramine maleate/bromhexine
  • promegestone
  • batroxobin
  • bencyclane
  • benfluorex
  • acetylpheneturide
  • abarelix
  • abetimus
  • naftidrofuryl
  • nalorphine
  • oxiracetam
  • letosteine
  • lafutidine
  • leuprorelin
  • levodropropizine
  • glutaral
  • losartan/ramipril
  • gallopamil
  • lanatoside c
  • lauromacrogol
  • gestodene
  • aceclofenac/methyl salicylate/menthol/linseed oil/capsaicin
  • aceclofenac/paracetamol/tizanidine
  • alginic acid/magaldrate/simethicone
  • aceclofenac/paracetamol
  • aceclofenac/rabeprazole
  • alginic acid
  • pantoprazole and domperidone
  • urokinase
  • rimiterol
  • olanzapine/fluoxetine
  • normethadone/hydroxyephedrine
  • myrtol
  • moxonidine
  • propylhexedrine
  • sodium hypochlorite solution
  • sodium chloride/sodium citrate
  • Hepatitis B Vaccine (Recombinant [Adjuvanted])
  • Hepatitis B Vaccine (Recombinant)
  • aceclofenac and serratiopeptidase
  • levosulpiride
  • niaprazine
  • tromantadine
  • trimetazidine
  • vinburnine
  • mizoribine
  • molgramostim
  • mosapride
  • eugenol
  • tolperisone
  • etamsylate
  • etynodiol
  • mizolastine
  • metenolone
  • reproterol
  • rebamipide
  • mephenoxalone
  • metandienone
  • furosemide/spironolactone
  • hydroxycarbamide
  • tenonitrozole
  • fenoverine
  • fenquizone
  • tiapride
  • tibolone
  • furazolidone
  • furosemide & amiloride
  • fosfestrol
  • fluclorolone
  • flubendazole
  • tertatolol
  • tetracosactide
  • tetryzoline
  • tolciclate
  • trapidil
  • troxipide
  • temoporfin
  • telbivudine
  • teprenone
  • hexamidine
  • mebhydrolin
  • mepartricin
  • fencamfamin
  • medazepam
  • theodrenaline
  • thiamazole
  • thiocolchicoside
  • psilocybin
  • veralipride
  • pyritinol
  • opipramol
  • oprelvekin
  • betamethasone + gentamicin
  • betamethasone + neomycin
  • betamethasone + salicylic acid
  • oxedrine
  • bopindolol
  • orgotein (investigational)
  • oxaceprol
  • ormeloxifene
  • bevantolol
  • bifemelane
  • clebopride
  • demoxytocin
  • cicletanine
  • cefsulodin
  • chlortalidon
  • sisomicin
  • somatrem
  • carbazochrome
  • caroverine
  • cathine
  • ipriflavone
  • isepamicin
  • silymarin
  • simethicone
  • sermorelin
  • diloxanide
  • dimethindene
  • diosmin/hesperidin
  • calamine
  • canrenone
  • captodiame
  • imidapril
  • cefetamet
  • cefodizime
  • cefoperazone + sulbactam
  • ivermectin + albendazole
  • serrapeptase
  • bromisoval
  • beraprost
  • pridinol
  • proglumide
  • bamipine
  • barnidipine
  • bamifylline
  • benzbromarone
  • betamethasone/fusidic acid
  • para-chlorophenol
  • pantethine
  • nomifensine
  • pemoline
  • parnaparin
  • pentolinium
  • nialamide
  • novobiocin
  • nicergoline
  • octocrylene
  • octisalate
  • oftasceine
  • oxolamine
  • oxyphencyclimine
  • penfluridol
  • pentoxyverine
  • phenoxymethylpenicillin
  • picloxydine
  • pilsicainide hydrochloride
  • piperazine
  • pirarubicin
  • policresulen
  • prifinium bromide
  • prethcamide
  • pristinamycin
  • pirenzepine
  • piribedil
  • pimethixene
  • pargyline
  • phosphatidyl choline
  • phthalylsulfathiazole
  • phytomenadione
  • pranlukast
  • pinazepam
  • oxyphenonium
  • noxytiolin
  • periciazine
  • pethidine
  • phenindamine
  • histidine
  • isoleucine
  • proline
  • lauric acid
  • lymecycline
  • hypromellose
  • abiraterone acetate and niraparib
  • ichthammol
  • levamisole
  • naftazone
  • nefopam
  • oxprenolol
  • oxybuprocaine
  • elranatamab-bcmm
  • lapyrium
  • isoaminile
  • iotrolan
  • mazindol
  • masoprocol
  • lypressin
  • meradimate
  • molsidomine
  • monobenzone
  • mequinol/gluconolactone/ lactobionic acid/ arbutin
  • medifoxamine
  • mebutamate
  • metergoline
  • methantheline
  • methdilazine
  • metocurine
  • micronomicin
  • metaraminol
  • mephenesin
  • menadione
  • medrysone
  • metixene
  • levobetaxolol
  • guaiacol glycerol ether
  • eucalyptol
  • sodium tetradecyl sulfate
  • sugammadex
  • carbetocin
  • certoparin
  • chlorcyclizine/pseudoephedrine
  • cephapirin
  • indecainide
  • iobitridol
  • iomeprol
  • chlorphenesin
  • msud analog
  • msud maxamum
  • iceland moss
  • glutethimide
  • hexachlorophene
  • haloprogin
  • deferoxamine
  • ethchlorvynol
  • dexpanthenol topical
  • etilefrine
  • deslanoside
  • carbocromen
  • diazolidinylurea
  • dibenzepin
  • etofamide
  • guanoxan
  • halazepam
  • guanadrel sulfate
  • dapiprazole
  • soapwort
  • debrisoquine
  • l-tryptophan
  • chlormerodrin
  • chlorquinaldol
  • cetrimonium
  • carbocisteine
  • chlorcyclizine/codeine
  • technetium Tc-99m tetrofosmin
  • technetium Tc-99m disofenin
  • technetium Tc-99m gluceptate
  • technetium Tc-99m labeled red blood cells
  • amylmetacresol/dextromethorphan hydrobromide
  • anileridine phosphate
  • pyrethrins
  • pyrantel pamoate
  • quinagolide
  • spiramycin
  • standard hyperkalemic cardioplegia solution
  • technetium tc-99m mertiatide
  • technetium tc-99m medronate
  • bemotrizinol / bisoctrizole
  • benfotiamine
  • bemotrizinol + titanium dioxide + zinc oxide
  • technetium Tc-99m oxidronate
  • technetium Tc-99m pentetate
  • technetium Tc-99m pyrophosphate
  • benziodarone
  • octinoxate/bisoctrizole
  • bicisate dihydrochloride
  • technetium Tc-99m bicisate
  • norelgestromin/ethinyl estradiol
  • norgestimate/ethinyl estradiol
  • ximelagatran (investigational)
  • xamoterol
  • trioxsalen
  • poly-urea urethane
  • rilmenidine
  • pemirolast
  • oxitriptan
  • beclomethasone, intranasal
  • thimerosal
  • camphor gel
  • camphor
  • mumps virus vaccine, live
  • rubella virus vaccine, live
  • aluminum chloride (dental)
  • alum irrigation
  • framycetin, phenylephrine, and gramicidin
  • ombitasvir, paritaprevir, ritonavir, and dasabuvir
  • olipudase alfa
  • etonogestrel/ethinyl estradiol
  • mycophenolate
  • fluoroestradiol F 18
  • donor organ cardioplegia solution
  • fluciclovine F 18
  • fusidic acid (ophthalmic)
  • fusidic acid and hydrocortisone
  • framycetin, dexamethasone, and gramicidin
  • fludeoxyglucose F-18
  • fluorouracil/salicylic acid
  • indium In-111 oxyquinoline
  • indium In-111 pentetreotide
  • indium In-111 capromab pendetide
  • lusutrombopag
  • mitomycin (ophthalmic)
  • mifepristone and misoprostol
  • minoxidil (systemic)
  • methyl aminolevulinate (topical)
  • methyl folate, methylcobalamin, and acetylcysteine
  • ciclesonide/formoterol/tiotropium
  • nedocromil (Oral Inhalation)
  • batefenterol (Investigational)
  • neostigmine and glycopyrrolate
  • nepafenac ophthalmic
  • netupitant/palonosetron
  • meperidine and promethazine
  • mepivacaine and levonordefrin
  • maltodextrin
  • medical cannabis
  • medium chain triglycerides
  • mometasone/glycopyrrolate (glycopyrronium)/ indacaterol
  • moxifloxacin ophthalmic
  • neomycin/fluocinolone
  • nadroparin
  • iodine I-125 iothalamate
  • amikacin liposome (oral inhalation)
  • bupivacaine liposome
  • natamycin
  • lopinavir and ritonavir
  • lysine
  • macitentan and tadalafil
  • mitomycin pyelocalyceal
  • moclobemide
  • mometasone and indacaterol
  • efinaconazole
  • blue-green algae
  • indocyanine green
  • follitropin beta
  • lumasiran
  • glycerin/lidocaine
  • edrophonium/atropine
  • indigo carmine
  • lutropin alfa
  • instant glucose/intravenous dextrose
  • iobenguane I-123
  • ixekizumab
  • isosulfan blue dye
  • levofloxacin ophthalmic
  • levonorgestrel oral/ferrous bisglycinate/ ethinylestradiol
  • ethinyl estradiol/levonorgestrel transdermal
  • hydroquinone
  • hydroxypropyl methylcellulose
  • icodextrin
  • lipid emulsion (soybean, medium-chain triglyceride, olive, and fish oils; [SMOF])
  • iodinated I 125 albumin
  • iodinated I 131 albumin
  • lipid emulsion (plant oil-based)
  • levonorgestrel intrauterine
  • levonorgestrel oral/ethinyl estradiol
  • lactic acid and sodium-PCA
  • lactated Ringer solution
  • ketotifen (systemic)
  • lanolin
  • leuprolide and norethindrone
  • levodopa and benserazide
  • gonadorelin acetate
  • hemodialysis solutions
  • nirsevimab
  • gentian violet
  • gallium ga-68 dotatate
  • fusidic acid and betamethasone
  • gallium citrate Ga-67
  • gadopentetate dimeglumine
  • gadofosveset
  • follitropin delta
  • follitropin alfa and lutropin alfa
  • follitropin alfa
  • rocatinlimab
  • grass pollens allergen extract
  • flotufolastat F18
  • fluorescein ophthalmic
  • barium
  • balanced salt solution
  • air polymer type A intrauterine device
  • clodronate
  • bentoquatam
  • clobetasone
  • alfacalcidol
  • citric acid/glucono-delta-lactone/magnesium carbonate
  • benzoin
  • desirudin
  • immune globulin IV (IGIV)
  • dequalinium
  • pseudoephedrine/desloratadine
  • clofedanol
  • cyproterone and ethinyl estradiol
  • dextranomer and hyaluronic acid or derivatives
  • diatrizoate meglumine and diatrizoate sodium
  • glucosamine sulfate, chondroitin sulfate and Msm
  • squill
  • gotu kola
  • blessed thistle
  • bitter melon
  • apraclonidine
  • chlophedianol/dexbrompheniramine/pseudoephedrine
  • wild jujube
  • chitosan
  • cilazapril/hydrochlorothiazide
  • dexbrompheniramine and phenylephrine
  • diethylene triamine penta-acetic acid
  • dexchlorpheniramine and pseudoephedrine
  • lily of the valley
  • diflucortolone
  • corydalis
  • lemon balm
  • MSM
  • calcium polystyrene sulfonate
  • caprylidene
  • peppermint oil
  • efavirenz/lamivudine/tenofovir DF
  • emtricitabine/tenofovir DF /efavirenz
  • dutasteride/tamsulosin
  • milk thistle
  • centaury
  • horseweed
  • lycopus
  • agrimony
  • alfalfa
  • kava
  • cetrorelix
  • cetylpyridinium
  • chlophedianol and dexbrompheniramine
  • betahistine
  • choline C-11
  • boric acid vaginal suppository
  • aluminum acetate
  • aluminum chloride hexahydrate
  • 14-C urea breath test
  • absorbable collagen
  • valoctocogene roxaparvovec-rvox
  • amlodipine and celecoxib
  • aspirin and omeprazole
  • azilsartan and chlorthalidone
  • landiolol (Pending FDA approval)
  • isosorbide dinitrate/hydralazine
  • losartan/hydrochorothiazide
  • udenafil
  • dextromethorphan/quinidine
  • onasemnogene abeparvovec
  • orphenadrine/aspirin/caffeine
  • trace elements
  • sodium phenylbutyrate/ taurursodiol
  • fish oil triglycerides
  • infant formula
  • glutamine
  • chloroquine phosphate
  • afatinib
  • quinidine gluconate
  • methylergonovine
  • prothrombin complex concentrate, human
  • BCG intravesical live
  • capivasertib
  • cedazuridine
  • carbonyl iron
  • iron dextran complex
  • lovotibeglogene autotemcel (FDA Approval Pending)
  • sodium benzoate/sodium phenylacetate
  • mineral oil otic
  • zolmitriptan transdermal
  • midazolam intranasal
  • fosinopril/hydrochlorothiazide
  • caplacizumab
  • arginine
  • sodium phenylbutyrate
  • meloxicam/rizatriptan
  • manganese
  • acetaminophen/pamabrom/pyridoxine
  • varicella zoster immune globulin, human
  • amitriptyline/perphenazine
  • narsoplimab (Pending FDA Approval)
  • amlodipine/perindopril
  • imiglucerase
  • canagliflozin/metformin
  • tafamidis meglumine
  • somatrogon-ghla
  • glimepiride/rosiglitazone
  • becaplermin
  • lithium
  • loxapine inhaled
  • nicotine transdermal
  • tixagevimab and cilgavimab (Investigational)
  • muromonab CD3
  • ansuvimab
  • coal tar bath products
  • fibrin sealant
  • arimoclomol (FDA Approval Pending)
  • varenicline intranasal
  • aducanumab
  • oxycodone/naloxone
  • ritlecitinib
  • sodium polystyrene sulfonate
  • calcipotriene/betamethasone
  • calcium hydroxylapatite
  • cantharidin topical
  • doxepin cream
  • clocortolone
  • formaldehyde topical
  • sodium sulfide topical
  • collagenase
  • selegiline transdermal
  • foscarbidopa/foslevodopa (FDA approval pending)
  • saxagliptin/metformin
  • linagliptin/metformin
  • linzagolix (FDA approval pending)
  • efgartigimod/hyaluronidase SC
  • elamipretide (Pending FDA approval)
  • rozanolixizumab
  • diazoxide
  • glimepiride/pioglitazone
  • cipaglucosidase alfa
  • dihydroergotamine intranasal
  • delandistrogene moxeparvovec
  • beremagene geperpavec
  • hyaluronic acid and derivatives
  • hyaluronic acid, non-animal stabilized
  • eplontersen (FDA Approval Pending)
  • nitric oxide gas
  • sodium phenylbutyrate and taurursodiol
  • treprostinil SC
  • viltolarsen
  • albuterol/ipratropium
  • budesonide inhaled
  • budesonide rectal
  • palovarotene
  • sodium sulfate/potassium chloride/magnesium sulfate/polyethylene glycol
  • amino acids mixture
  • aminobenzoate potassium
  • elivaldogene autotemcel
  • naproxen and sumatriptan
  • sumatriptan intranasal
  • alglucerase
  • metformin/rosiglitazone
  • ertugliflozin/metformin
  • elosulfase alfa
  • calcium carbonate/magnesium hydroxide
  • starch suppository
  • abicipar pegol (FDA Approval Pending)
  • riboflavin 5′-phosphate ophthalmic
  • povidone ophthalmic
  • glycerin oropharyngeal
  • dimethicone topical
  • menthol topical, dimethicone topical
  • pramoxine topical, menthol topical and dimethicone topical
  • phosphorated carbohydrate
  • brilliant blue G ophthalmic
  • brolucizumab intravitreal
  • purified water, ophthalmic
  • hydroxyethyl cellulose ophthalmic
  • ranibizumab intravitreal implant
  • sodium chloride hypertonic, ophthalmic 
  • cetirizine ophthalmic
  • phentolamine ophthalmic
  • ganciclovir ophthalmic
  • triamcinolone intravitreal
  • ocriplasmin intravitreal
  • atoltivimab/maftivimab/odesivimab
  • pegcetacoplan intravitreal
  • triamcinolone acetonide extended-release injectable suspension
  • tobramycin/loteprednol ophthalmic
  • 2-octyl cyanoacrylate
  • vitamins A & D topical
  • diphenhydramine/allantoin topical
  • pyrethrins/piperonyl butoxide
  • lodoxamide ophthalmic
  • obeticholic acid
  • fluocinolone intravitreal implant
  • sincalide
  • linaclotide
  • nedocromil ophthalmic
  • cysteamine ophthalmic
  • avacincaptad pegol intravitreal
  • azelastine ophthalmic
  • bacitracin ophthalmic
  • propylene glycol ophthalmic
  • rimexolone ophthalmic
  • metoclopramide intranasal
  • mirikizumab
  • netarsudil ophthalmic
  • cenegermin
  • dexamethasone ophthalmic insert
  • prednisolone ophthalmic
  • phenylephrine and cocoa butter rectal
  • phenylephrine and witch hazel topical
  • phenylephrine, pramoxine, glycerin and petrolatum rectal
  • bisacodyl rectal
  • aluminum hydroxide/magnesium carbonate
  • aluminum hydroxide/magnesium hydroxide
  • hyoscyamine spray
  • methenamine/methylene blue/ hyoscyamine/ sodium phosphate monobasic/ phenyl salicylate
  • phenylephrine
  • chlorophyll
  • castor oil
  • cholic acid
  • phenol oropharyngeal
  • articaine/epinephrine
  • antithymocyte globulin equine
  • aluminum hydroxide/magnesium trisilicate
  • methenamine/hyoscyamine
  • hydrocortisone topical/pramoxine topical 
  • sodium fluoride topical
  • mesna
  • C1 esterase inhibitor recombinant
  • menthol and pectin
  • menthol oropharyngeal
  • pectin oropharyngeal
  • gepirone
  • Goldenseal
  • polyethylene glycol and electrolytes
  • polyethylene glycol/electrolytes/sodium ascorbate/ascorbic acid
  • brompheniramine/pseudoephedrine/dextromethorphan
  • brompheniramine phenylephrine
  • acetaminophen/doxylamine/phenylephrine
  • doxylamine/acetaminophen/pseudoephedrine/dextromethorphan
  • acetaminophen/doxylamine/dextromethorphan
  • acetaminophen/doxylamine/dextromethorphan/phenylephrine
  • eslicarbazepine
  • fluticasone and salmeterol
  • codeine, acetaminophen, butalbital and caffeine
  • codeine, chlorpheniramine and phenylephrine
  • iodine
  • povidone iodine
  • butalbital/aspirin/caffeine/codeine
  • polyethylene glycol 400/propylene glycol ophthalmic 
  • pegvaliase
  • amivantamab
  • iopamidol
  • codeine and pseudoephedrine
  • emtricitabine, rilpivirine, tenofovir DF
  • penicillin G aqueous
  • miconazole topical
  • miconazole vaginal
  • ciprofloxacin inhaled (Pending FDA approval)
  • ceftazidime/avibactam
  • ceftolozane/​tazobactam
  • aztreonam inhalation
  • amphotericin B cholesteryl sulfate
  • miconazole oral
  • elvitegravir/cobicistat/emtricitabine/tenofovir DF
  • isavuconazonium sulfate
  • dapivirine intravaginal (FDA Approval Pending)
  • lamivudine/raltegravir
  • codeine/triprolidine/pseudoephedrine
  • cadexomer iodine
  • brompheniramine/pseudoephedrine
  • codeine/acetaminophen
  • codeine/guaifenesin
  • beclomethasone inhaled
  • epoetin beta/methoxy polyethylene glycol
  • voreloxin(Orphan Drug)
  • rociletinib
  • pitcher plant
  • phosphatidylserine
  • telotristat ethyl
  • copper CU 64 dotatate
  • urea topical
  • exenatide subdermal implant
  • asenapine transdermal
  • ethiodized oil
  • urea oral
  • miglustat
  • acalisib(Investigational)
  • acetophenazine
  • guggul
  • aceneuramic acid
  • mestranol/norethindrone
  • reishi
  • lactitol
  • vonoprazan fumarate
  • motherwort
  • silver nitrate
  • salicylic acid/sulfur shampoo
  • salicylic acid topical
  • ketorolac ophthalmic
  • ketoconazole topical
  • Japanese encephalitis virus vaccine
  • dibucaine topical ointment
  • ketorolac intranasal
  • ketorolac/phenylephrine ophthalmic
  • rotavirus oral vaccine, live
  • guarana
  • hops
  • krill oil
  • salicylic acid/coal tar shampoo
  • sufentanil SL
  • pancrelipase
  • passion flower
  • pepdite one plus
  • nivolumab and relatlimab
  • relatlimab (Pending FDA Approval)
  • benzalkonium chloride/benzocaine
  • ketotifen, drug-eluting contact lens
  • calcitriol topical
  • oxymetazoline topical
  • alclometasone topical
  • capsaicin topical
  • diclofenac/misoprostol
  • diclofenac ophthalmic
  • diclofenac topical
  • pramoxine/calamine topical
  • veverimer
  • tolazoline
  • olopatadine ophthalmic
  • lutetium lu 177-dota-tate
  • lutetium lu 177 vipivotide tetraxetan
  • strontium 89 chloride
  • interferon alfa n3
  • lutetium Lu 177- Diethylenetriamine Pentaacetic acid-omburtamab (FDA Approval Pending)
  • samarium sm 153 lexidronam
  • cytomegalovirus immune globulin (CMV IG)
  • antithymocyte globulin rabbit
  • inolimomab (Pending FDA Approval)
  • olopatadine intranasal
  • olopatadine intranasal/​mometasone, intranasal
  • benzocaine/butamben/tetracaine topical
  • antipyrine/benzocaine/phenylephrine
  • dyclonine/menthol
  • surufatinib
  • fruquintinib
  • tepotinib 
  • dostarlimab
  • hepatitis B immune globulin (HBIG)
  • remestemcel-L
  • benzocaine/menthol oropharyngeal
  • interferon beta 1b
  • tetracaine/oxymetazoline intranasal
  • benzocaine oropharyngeal
  • benzalkonium chloride/menthol/petrolatum topical
  • inamrinone
  • alpha 1 proteinase inhibitor
  • potassium bicarbonate/potassium citrate
  • potassium phosphate/sodium acid phosphate
  • asparaginase Erwinia chrysanthemi recombinant
  • motixafortide
  • pegloticase
  • etesevimab
  • Rho(D) immune globulin
  • tetanus immune globulin (TIG)
  • reltecimod (pending FDA approval)
  • avasopasem
  • trimethoprim/polymyxin B ophthalmic
  • naphazoline ophthalmic
  • sulfacetamide topical
  • sirolimus intravitreal (pending FDA approval)
  • sirolimus protein bound
  • sirolimus topical
  • glycopyrronium tosylate topical
  • sofpironium
  • olmesartan, amlodipine and hydrochlorothiazide
  • dovitinib (Pending FDA Approval)
  • epinephrine inhaled
  • quizartinib (Pending FDA Approval)
  • ranibizumab intravitreal injection
  • sodium hyaluronate
  • bacitracin and lidocaine topical
  • brimonidine topical
  • benzoyl peroxide and tretinoin topical
  • talquetamab
  • betrixaban
  • acetaminophen/caffeine/pyrilamine
  • fentanyl transmucosal
  • bacitracin topical
  • buprenorphine,long-acting injection
  • buprenorphine buccal
  • nalmefene intranasal
  • sulbactam/durlobactam
  • metronidazole topical 
  • daratumumab/hyaluronidase
  • glofitamab
  • rituximab-hyaluronidase
  • drospirenone/ethinyl estradiol/levomefolate
  • loncastuximab tesirine
  • ingenol mebutate topical
  • momelotinib
  • trastuzumab/deruxtecan
  • trastuzumab/hyaluronidase
  • trastuzumab duocarmazine
  • lifileucel
  • umbralisib
  • eflornithine/sulindac
  • cytarabine/daunorubicin liposomal
  • doxorubicin liposomal
  • epcoritamab
  • lanadelumab  
  • esomeprazole/naproxen 
  • terbinafine topical
  • ravulizumab
  • clotrimazole topical
  • choline magnesium trisalicylate
  • tacrolimus ointment
  • mechlorethamine topical
  • donislecel
  • pozelimab (Pending FDA Approval)
  • human rabies immune globulin (HRIG)
  • melphalan flufenamide
  • sintilimab (Pending FDA Approval)
  • oportuzumab monatox (Pending FDA Approval)
  • sotorasib
  • irinotecan liposomal
  • sulfur topical
  • silver sulfadiazine
  • capsaicin transdermal
  • sutimlimab
  • tretinoin topical
  • acetaminophen rectal
  • menthol topical
  • naftifine
  • oatmeal, colloidal topical
  • oxiconazole
  • methylsalicylate/menthol topical
  • C1 inhibitor human
  • lifitegrast ophthalmic
  • prednisolone/sulfacetamide ophthalmic
  • mannitol inhalation
  • ofloxacin otic
  • petrolatum & mineral oil topical
  • clascoterone topical
  • gefapixant (Pending FDA Approval)
  • colesevelam
  • technetium Tc 99m succimer
  • nebivolol/valsartan
  • ciprofloxacin/fluocinolone acetonide, otic
  • finafloxacin otic
  • magnesium hydroxide/mineral oil
  • phenylephrine/mineral oil/petrolatum rectal
  • carbamide peroxide oral
  • atropine ophthalmic
  • sodium sulfacetamide/sulfur
  • sulfacetamide ophthalmic
  • lucinactant
  • benzonatate
  • besifloxacin ophthalmic
  • benzhydrocodone/acetaminophen
  • beractant
  • trimagnesium citrate anhydrous
  • vitamin b2
  • carbamide peroxide otic
  • mineral oil topical
  • ethyl alcohol intranasal
  • boric acid/alcohol otic
  • absorbable gelatin compressed sponge, USP
  • absorbable gelatin sponge, USP
  • vincristine liposomal
  • technetium Tc 99m albumin aggregated injection
  • metaproterenol
  • budesonide inhaled/formoterol/glycopyrrolate inhaled
  • epinephrine racemic
  • umeclidinium bromide/vilanterol inhaled
  • indacaterol, inhaled/glycopyrrolate inhaled
  • betaine  
  • laronidase 
  • estrogens esterified/methyltestosterone            
  • cerliponase alfa
  • ertugliflozin/sitagliptin
  • hawthorn
  • shepherd’s purse
  • thiamine
  • naphazoline/glycerin ophthalmic
  • oxymetazoline ophthalmic
  • dorzolamide
  • dexamethasone intraocular
  • dexamethasone/ciprofloxacin
  • dexamethasone ophthalmic
  • metipranolol ophthalmic
  • timolol ophthalmic
  • boron
  • fezolinetant
  • pegunigalsidase alfa-iwxj
  • biotin
  • pantothenic acid
  • silicon
  • sodium acid phosphate
  • hypochlorous acid topical
  • methenamine/sodium acid phosphate
  • aviptadil 
  • bremelanotide
  • glucagon intranasal
  • metformin and repaglinide
  • bai ji
  • pau d’arco
  • juzentaihoto
  • mistletoe
  • quercetin
  • rosemary
  • sheng di huang
  • chasteberry
  • maitake
  • grapefruit
  • lentinan
  • juniper
  • nettle
  • parsley
  • rose hips
  • tongkat ali
  • horny goat weed
  • damiana
  • yohimbe
  • insulin NPH
  • aprocitentan
  • noni Juice
  • sodium iodide I-131
  • green tea
  • sea cucumber
  • wheat germ extract
  • fenofibrate micronized 
  • rogisen
  • danshen
  • lutein
  • witch hazel
  • dextroamphetamine transdermal
  • amphetamine/dextroamphetamine
  • hoodia
  • kolanut
  • boswellia
  • opuntia ficus indica
  • lavender
  • nadh
  • tea tree oil
  • metformin/sitagliptin 
  • dapagliflozin/ metformin/saxagliptin  
  • antihemophilic factor recombinant
  • inclisiran
  • bempedoic acid/ezetimibe
  • volanesorsen  
  • omega 3 carboxylic acids
  • pericyazine
  • levomepromazine (methotrimeprazine)
  • betaxolol ophthalmic
  • respiratory syncytial virus vaccine, adjuvanted
  • phenylephrine hydrochloride and tropicamide ophthalmic
  • alirocumab
  • neomycin/polymyxin B/gramicidin ophthalmic
  • factor IX
  • gentamicin topical
  • ansofaxine (Pending FDA Approval)
  • zuranolone
  • factor IX, recombinant
  • factor IX complex
  • factor XIII A-subunit, recombinant
  • factor X, human
  • mesalamine rectal
  • etrasimod
  • anti-inhibitor coagulant complex
  • factor IX, recombinant/albumin fusion protein
  • fibrinogen, human
  • aminocaproic acid
  • metyrosine
  • nonoxynol-9 vaginal
  • progesterone intravaginal gel
  • ipecac syrup
  • botulinum antitoxin, heptavalent
  • pentetate calcium trisodium
  • crotalidae polyvalent immune FAB (ovine)
  • dehydrated alcohol injection 
  • gold sodium thiomalate (Discontinued)
  • lactic acid/citric acid/potassium bitartrate vaginal
  • von Willebrand factor, recombinant
  • luspatercept
  • digoxin immune FAB (Antidote)
  • crotalidae immune FAB (equine)
  • magnesium (Antidote)
  • pyridoxine (Antidote)
  • edetate calcium disodium
  • albumin IV
  • nitroglycerin sublingual
  • obiltoxaximab
  • anthrax immune globulin
  • nitroglycerin topical
  • dextrose
  • nesiritide
  • estradiol vaginal
  • bazedoxifene/conjugated estrogens
  • botulism immune globulin iv
  • amoxicillin/omeprazole/rifabutin
  • synthetic human angiotensin II
  • nitroglycerin IV
  • nitroglycerin translingual
  • nitroprusside sodium
  • tetrahydrozoline/zinc sulfate/hypromellose ophthalmic
  • sodium citrate/citric acid
  • pemetrexate
  • methicillin
  • plasminogen 
  • acai
  • american ginseng
  • cordyceps
  • tramadol/acetaminophen
  • belladonna alkaloids/phenobarbital
  • erythromycin topical/benzoyl peroxide
  • glucosamine sulfate
  • panax ginseng (suppl/herb)
  • tolnaftate
  • sulopenem etzadroxil/probenecid
  • sulfur hexafluoride
  • sotrovimab
  • arbaclofen
  • rifampin/isoniazid
  • clindamycin /tretinoin topical
  • benzoyl peroxide/clindamycin topical
  • apremilast
  • antivenins, centuroides (scorpion)
  • bamlanivimab and etesevimab
  • vilobelimab
  • gadobenate
  • pentosan polysulfate sodium
  • methylsalicylate/menthol/camphor topical
  • antivenin, black widow spider
  • benzoyl peroxide and hydrocortisone
  • clindamycin topical
  • isometheptene, dichloralphenazone and acetaminophen
  • acetaminophen and phenyltoloxamine
  • erythromycin topical
  • erythromycin ophthalmic
  • alpha hydroxy acids, topical
  • buprenorphine transdermal
  • butalbital/acetaminophen/caffeine
  • buprenorphine/samidorphan
  • buprenorphine subdermal implant
  • celecoxib/tramadol
  • drospirenone/ethinyl estradiol
  • resorcinol/sulfur
  • eflornithine
  • rifampin/isoniazid/pyrazinamide
  • tofersen
  • devil’s claw
  • ticarcillin/clavulanate
  • atropine/pralidoxime
  • aprepitant
  • suramin
  • phenelzine 
  • artichoke
  • american dogwood
  • attapulgite
  • atlantic cedar
  • axalimogene filolisbac
  • sodium thiosulfate & sodium nitrite
  • ataluren
  • omidubicel-onlv
  • capsicum
  • ginger
  • cryoprecipitate
  • bictegravir/emtricitabine/tenofovir DF
  • emtricitabine/tenofovir DF
  • fo-ti
  • siberian ginseng
  • granulocytes
  • zinc substituted heme C
  • zinc trihydroxide
  • ashwagandha 
  • cat’s claw
  • glandular products
  • SAMe
  • shark cartilage
  • altovis
  • feverfew
  • horse chestnut
  • magnesium aspartate
  • octacosanol
  • pleurisy root
  • star anise
  • butterbur
  • elderberry
  • licorice (Suppl/herb)
  • aconite
  • pentetate zinc trisodium
  • menthol topical/zinc oxide topical
  • corn-starch/kaolin/zinc oxide topical
  • 5-htp
  • butcher’s broom
  • articulin
  • bearberry
  • goldenrod
  • progesterone, natural
  • black cohosh
  • wild yam
  • cranberry
  • dong quai
  • phytoestrogens
  • norethindrone
  • false Unicorn Root
  • raspberry Leaf
  • asafoetida
  • turmeric
  • dehydroepiandrosterone (DHEA)
  • hyaluronan
  • aliskiren/amlodipine
  • octreotide (Antidote)
  • tranexamic acid injection
  • duocal
  • neocate infant formula
  • pediatric Eo28
  • aloe
  • red clover
  • propolis
  • androstenedione
  • heartsease
  • comfrey
  • bilberry
  • chamomile
  • eyebright
  • calendula
  • sage
  • yucca
  • polypody
  • odevixibat
  • vinpocetine
  • olanzapine/samidorphan
  • creatine
  • yerba mate
  • spesolimab
  • azficel-T
  • tiludronate
  • estetrol and drospirenone
  • pseudoephedrine/fexofenadine
  • lincomycin
  • neomycin oral
  • fluocinolone acetonide, otic
  • tretinoin/ hydroquinone/ fluocinolone
  • halobetasol topical
  • hydrocortisone/​iodoquinol
  • penicillin G procaine /penicillin G benzathine
  • hydrocortisone probutate topical
  • colistin/neomycin/hydrocortisone/thonzonium otic
  • ebola zaire vaccine
  • hepatitis a/​b vaccine
  • vibegron
  • lindane
  • nystatin topical
  • respiratory syncytial virus (RSV) vaccine
  • chikungunya vaccine, live
  • tenecteplase
  • reteplase
  • anthrax vaccine adsorbed, adjuvanted
  • meningococcal ABCWY pentavalent vaccine
  • eculizumab
  • cholestyramine
  • tinzaparin
  • taurolidine/​citrate/​heparin
  • protein C concentrate
  • antithrombin alfa
  • antithrombin III
  • multivitamins, vision
  • ibuprofen/​chlorpheniramine/​pseudoephedrine
  • acetaminophen/ibuprofen
  • ibuprofen/pseudoephedrine
  • paclitaxel protein-bound
  • acetic acid vaginal
  • acetic acid otic
  • hydrocodone/ ibuprofen
  • methyl salicylate / isopropanol/ citronellyl acetate/ citric acid
  • ibuprofen and phenylephrine
  • acetylcysteine (Antidote)
  • iron/​folic acid/​vitamin/​mineral
  • iobenguane I-131
  • dolutegravir/rilpivirine
  • chlorhexidine topical
  • chlorhexidine oral
  • thyroid desiccated
  • proparacaine ophthalmic
  • podophyllum resin
  • phendimetrazine
  • phenoxybenzamine
  • polidocanol
  • phentermine and topiramate
  • piflufolastat F18
  • piperacillin/tazobactam
  • prednisolone and gentamicin ophthalmic
  • promethazine and codeine
  • poractant alfa
  • protamine sulfate
  • aflibercept intravitreal
  • prednicarbate
  • promethazine/dextromethorphan
  • codeine, phenylephrine, and promethazine
  • potassium phosphate
  • glatiramer acetate
  • gentamicin (Ophthalmic)
  • leniolisib
  • rezafungin
  • fluorometholone
  • dalfampridine
  • hydrocortisone topical 
  • empagliflozin and linagliptin
  • triamcinolone topical
  • minocycline topical
  • minocycline dental
  • ketotifen ophthalmic
  • darunavir and cobicistat
  • lidocaine topical
  • neomycin/polymyxin B/bacitracin/lidocaine (OTC)
  • lidocaine/ hydrocortisone
  • lidocaine anesthetic
  • lidocaine ophthalmic
  • lidocaine/tetracaine
  • desonide
  • dabigatran
  • fexofenadine
  • fluoride
  • decitabine and cedazuridine
  • dasiglucagon
  • hydroxypropyl cellulose ophthalmic
  • epoetin alfa
  • ibritumomab tiuxetan
  • trimethobenzamide
  • dexamethasone/ tobramycin
  • tafasitamab
  • valacyclovir
  • mebendazole
  • levoleucovorin
  • flaxseed
  • germanium
  • glutathione
  • lycopene
  • pygeum
  • horseradish
  • ziv-aflibercept
  • micafungin
  • trofinetide
  • taliglucerase alfa
  • tildrakizumab
  • sulopenem (Pending FDA Approval)
  • thyrotropin alfa
  • birch
  • thrombin, topical
  • tivozanib
  • tafluprost
  • methohexital
  • urea and hydrocortisone
  • unoprostone ophthalmic
  • trihexyphenidyl
  • ezetimibe
  • evolocumab
  • trifluridine and tipiracil
  • methenamine
  • misoprostol
  • miltefosine
  • rimantadine
  • maralixibat
  • coenzyme Q10
  • chlorella
  • garlic
  • forskolin
  • zavegepant
  • menotropins
  • margetuximab
  • meprobamate
  • melarsoprol
  • evening primrose oil
  • lemongrass
  • molindone
  • fenugreek
  • phytosterols
  • red yeast rice
  • uridine triacetate
  • tropicamide
  • incobotulinumtoxinA
  • Grape Seed Extract
  • carbachol ophthalmic
  • cosyntropin
  • cyclopentolate and phenylephrine
  • carteolol ophthalmic
  • pentazocine/naloxone
  • pentazocine/acetaminophen
  • casimersen
  • carisoprodol, aspirin, and codeine
  • carisoprodol
  • carboprost tromethamine
  • flurandrenolide
  • brinzolamide/brimonidine
  • betamethasone topical
  • omaveloxolone
  • bardoxolone
  • allogeneic processed thymus tissue
  • fluocinolone topical
  • tacrolimus topical
  • ruxolitinib topical
  • pimecrolimus topical
  • sofosbuvir, velpatasvir and voxilaprevir
  • sofosbuvir/velpatasvir
  • mitotane
  • elbasvir/​grazoprevir
  • wheat dextrin
  • vanadium
  • iron/folic acid/vitamin/mineral
  • molybdenum
  • sparsentan
  • velmanase alfa-tycv
  • pegcetacoplan
  • ferrous sulfate
  • cyclosporine ophthalmic
  • ferric pyrophosphate
  • ammonium lactate
  • etelcalcetide
  • iodoquinol
  • sucroferric oxyhydroxide
  • doxercalciferol
  • terconazole vaginal
  • cortisone
  • pyronaridine
  • tetrahydrozoline, ophthalmic
  • tenapanor
  • tesamorelin
  • benazepril/hydrochlorothiazide
  • nadolol and bendroflumethiazide
  • spironolactone and hydrochlorothiazide
  • COVID-19 Vaccine, mRNA
  • atosiban
  • bisoprolol and hydrochlorothiazide
  • ephedrine/guaifenesin
  • clonidine/chlorthalidone
  • captopril/hydrochlorothiazide
  • amlodipine/valsartan/hydrochlorothiazide
  • hydrochlorothiazide and irbesartan
  • candesartan/hydrochlorothiazide
  • ciclesonide intranasal
  • cromolyn sodium ophthalmic
  • methyldopa/hydrochlorothiazide
  • valsartan/hydrochlorothiazide
  • hydrochlorothiazide and triamterene
  • moexipril/hydrochlorothiazide
  • mometasone/intranasal
  • ofloxacin ophthalmic
  • cysteamine
  • metoprolol/hydrochlorothiazide
  • amlodipine/olmesartan
  • eprosartan/hydrochlorothiazide
  • amlodipine/telmisartan
  • hydrochlorothiazide/aliskiren
  • betamethasone/clotrimazole
  • telmisartan/hydrochlorothiazide
  • benazepril/amlodipine
  • bezlotoxumab
  • propranolol/hydrochlorothiazide
  • bupropion/naltrexone
  • burosumab
  • acetylcholine chloride intraocular solution
  • bupivacaine and meloxicam
  • budesonide and formoterol (inhalation)
  • valerian
  • entacapone/levodopa/carbidopa
  • carbidopa/levodopa
  • calaspargase pegol
  • cabotegravir
  • cefixime
  • calfactant
  • brinzolamide
  • daprodustat
  • brimonidine and timolol
  • brodalumab
  • buprenorphine and naloxone
  • hydrocortisone acetic acid otic
  • butorphanol
  • butoconazole
  • adapalene and benzoyl peroxide
  • acrivastine and pseudoephedrine
  • neomycin/polymyxin B/bacitracin topical
  • midodrine
  • baloxavir marboxil
  • bacitracin, neomycin, polymyxin B, and hydrocortisone topical
  • avatrombopag
  • glucagon
  • atenolol/chlorthalidone
  • adefovir
  • activated charcoal
  • avalglucosidase alfa
  • aclidinium and formoterol
  • iclaprim (Pending FDA Approval)
  • ampicillin/sulbactam
  • quinupristin/dalfopristin
  • lamivudine/zidovudine/abacavir
  • acetaminophen and caffeine
  • acetaminophen/pamabrom
  • abacavir and lamivudine
  • anifrolumab
  • elacestrant
  • anidulafungin
  • acetohydroxamic acid
  • alogliptin/pioglitazone
  • anthralin
  • pirtobrutinib
  • gabapentin
  • galsulfase
  • gadoterate meglumine
  • ferric gluconate
  • ferric derisomaltose
  • ethanolamine oleate
  • eteplirsen
  • vasopressin
  • desmopressin
  • meropenem/vaborbactam
  • ecallantide
  • econazole topical
  • dornase alfa
  • aspirin/dipyridamole
  • dipyridamole
  • difenoxin and atropine
  • diflorasone
  • difluprednate ophthalmic
  • eptinezumab
  • diethylpropion
  • dexchlorpheniramine
  • dexmethylphenidate
  • serdexmethylphenidate/​dexmethylphenidate
  • bexagliflozin
  • galcanezumab
  • fremanezumab
  • tapinarof topical
  • darifenacin
  • dalbavancin
  • darbepoetin alfa
  • azilsartan
  • colestipol
  • corticorelin
  • crotamiton
  • crofelemer
  • allogeneic cultured keratinocytes/fibroblasts in bovine collagen
  • tapentadol
  • cyclopentolate
  • polymyxin B/bacitracin topical
  • tavaborole
  • tagraxofusp
  • crisaborole
  • crizanlizumab
  • satralizumab
  • spinosad
  • sacubitril/valsartan
  • sargramostim
  • sebelipase alfa
  • regadenoson
  • ribociclib/letrozole
  • ragweed allergen extract
  • radium-223 dichloride
  • secnidazole
  • setmelanotide
  • polycarbophil
  • plecanatide
  • sacituzumab govitecan
  • pertuzumab
  • pertuzumab/trastuzumab/hyaluronidase
  • pamidronate
  • halcinonide
  • glecaprevir/​pibrentasvir
  • glucarpidase
  • golodirsen
  • dextrose (antidote)
  • hexaminolevulinate
  • iohexol
  • ferric citrate
  • elapegademase
  • emicizumab
  • erenumab
  • danaparoid
  • dantrolene
  • eflapegrastim
  • edaravone
  • amcinonide
  • carglumic acid
  • alcaftadine ophthalmic
  • agalsidase beta
  • afamelanotide
  • fosdenopterin
  • lidocaine and chlorhexidine
  • levorphanol
  • calcifediol
  • factor VIIa, recombinant
  • triheptanoin
  • peanut oral allergen powder
  • teprotumumab
  • poly-L-lactic acid/carboxymethylcellulose/mannitol
  • xenon Xe 129 hyperpolarized
  • ublituximab
  • anacaulase
  • glatiramer
  • peginterferon beta-1a
  • interferon beta-1a
  • onabotulinumtoxinA
  • cycloserine
  • ethionamide
  • cabotegravir and rilpivirine
  • vericiguat
  • omidenepag isopropyl
  • azelastine/fluticasone intranasal
  • benzyl peroxide
enzalutamide + 

primidone

enzalutamide: they may diminish serum concentrations of the active metabolites of CYP3A4 inducers

phenobarbital

enzalutamide: they may diminish serum concentrations of the active metabolites of CYP3A4 inducers

carbamazepine

enzalutamide: they may diminish serum concentrations of the active metabolites of CYP3A4 inducers

efavirenz

enzalutamide: they may diminish serum concentrations of the active metabolites of CYP3A4 inducers

isoniazid

enzalutamide: they may diminish serum concentrations of the active metabolites of CYP3A4 inducers

phenobarbital 

may diminish serum concentrations of CYP3A4 Inducers

piflufolastat F18 

may decrease the diagnostic effect when combined with Piflufolastat F18

norethisterone 

the activity of norethisterone is reduced by administration of enzalutamide

atazanavir 

by affecting intestinal metabolism, the effect of enzalutamide may be increased

abemaciclib

CYP3A strong enhancers of the small intestine may reduce the the bioavailability of abemaciclib

abiraterone acetate

CYP3A strong enhancers of the small intestine may reduce the the bioavailability of abiraterone acetate

abrocitinib

CYP2C19 enhancers (moderate) may reduce the therapeutic efficacy of abrocitinib

acalabrutinib

CYP3A strong enhancers of the small intestine may reduce the the bioavailability of acalabrutinib

alfacalcidol

CYP3A strong enhancers of the small intestine may reduce the the bioavailability of alfacalcidol

alfentanil

CYP3A strong enhancers of the small intestine may reduce the the bioavailability of alfentanil

alpelisib

CYP3A strong enhancers of the small intestine may reduce the the bioavailability of alpelisib

alprazolam

CYP3A strong enhancers of the small intestine may reduce the the bioavailability of alprazolam

amiodarone

CYP3A strong enhancers of the small intestine may reduce the the bioavailability of amiodarone

amlodipine

CYP3A strong enhancers of the small intestine may reduce the the bioavailability of amlodipine

apixaban

CYP3A strong enhancers of the small intestine may reduce the bioavailability of apixaban

apremilast

CYP3A strong enhancers of the small intestine may reduce the bioavailability of apremilast

aprepitant

CYP3A strong enhancers of the small intestine may reduce the bioavailability of aprepitant

aripiprazole

CYP3A strong enhancers of the small intestine may reduce the bioavailability of aripiprazole

aripiprazole lauroxil

CYP3A enhancers may decrease plasma concentrations of the active metabolite(s) of aripiprazole lauroxil

artemether

CYP3A enhancers reduces plasma concentrations of the active metabolite(s) of artemether

asunaprevir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of asunaprevir

atazanavir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of atazanavir

atogepant

CYP3A strong enhancers of the small intestine may reduce the bioavailability of atogepant

atorvastatin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of atorvastatin

avacopan

CYP3A strong enhancers of the small intestine may reduce the bioavailability of avacopan

avanafil

CYP3A strong enhancers of the small intestine may reduce the bioavailability of avanafil

avapritinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of avapritinib

avatrombopag

enzalutamide may reduce the therapeutic efficacy of avatrombopag

axitinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of axitinib

barnidipine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of barnidipine

bedaquiline

CYP3A strong enhancers of the small intestine may reduce the bioavailability of bedaquiline

belumosudil

CYP3A strong enhancers of the small intestine may reduce the bioavailability of belumosudil

benidipine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of benidipine 

benperidol

CYP3A strong enhancers of the small intestine may reduce the bioavailability of benperidol

benzhydrocodone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of benzhydrocodone

betamethasone (systemic)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of betamethasone (systemic)

bictegravir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of bictegravir

bisoprolol

CYP3A strong enhancers of the small intestine may reduce the bioavailability of bisoprolol

blonanserin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of blonanserin 

bortezomib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of bortezomib

bosutinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of bosutinib

brentuximab vedotin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of brentuximab vedotin

brexpiprazole

CYP3A strong enhancers of the small intestine may reduce the bioavailability of brexpiprazole

brigatinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of brigatinib

brivaracetam

CYP2C19 enhancers (moderate) may reduce the therapeutic efficacy of brivaracetam 

bromocriptine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of bromocriptine 

bromperidol

CYP3A strong enhancers of the small intestine may reduce the bioavailability of bromperidol

buprenorphine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of buprenorphine

buspirone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of buspirone

butorphanol

CYP3A strong enhancers of the small intestine may reduce the bioavailability of butorphanol

cabazitaxel

CYP3A strong enhancers of the small intestine may reduce the bioavailability of cabazitaxel

cabozantinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of cabozantinib

calcifediol

CYP3A strong enhancers of the small intestine may reduce the bioavailability of calcifediol

calcitriol (systemic)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of calcitriol (systemic)

cannabidiol

CYP3A strong enhancers of the small intestine may reduce the bioavailability of cannabidiol

cannabis

CYP3A strong enhancers of the small intestine may reduce the bioavailability of cannabis

capmatinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of capmatinib

cariprazine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of cariprazine

carisoprodol

CYP2C19 enhancers may minimize the therapeutic activity of carisoprodol 

celecoxib

CYP2C9 enhancers may decrease the the bioavailability of celecoxib 

chlorpropamide

CYP3A strong enhancers of the small intestine may reduce the bioavailability of chlorpropamide enzal

choline c

antiandrogens may diminish the therapeutic effect of choline c 11 

cilnidipine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of cilnidipine 

citalopram

CYP3A strong enhancers of the small intestine may reduce the bioavailability of citalopram

clarithromycin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of clarithromycin

clindamycin (systemic)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of clindamycin (systemic)

clonazepam

CYP3A strong enhancers of the small intestine may reduce the bioavailability of clonazepam

clozapine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of clozapine

cobicistat

CYP3A strong enhancers of the small intestine may reduce the bioavailability of cobicistat 

cobimetinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of cobimetinib

codeine

CYP3A enhancers (strong) may decrease plasma concentrations of the active metabolite(s) of codeine

copanlisib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of copanlisib

crizotinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of crizotinib

cyclosporine (systemic)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of cyclosporine (systemic)

cyproterone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of cyproterone

daclatasvir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of daclatasvir

dapsone (systemic)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of dapsone (systemic)

daridorexant

CYP3A strong enhancers of the small intestine may reduce the bioavailability of daridorexant

darunavir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of darunavir

dasabuvir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of dasabuvir

dasatinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of dasatinib

deflazacort

CYP3A enhancers (strong) may decrease plasma concentrations of the active metabolite(s) of deflazacort

delamanid

CYP3A strong enhancers of the small intestine may reduce the bioavailability of delamanid

delavirdine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of delavirdine

dexamethasone (systemic)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of dexamethasone (systemic)

diazepam

CYP3A strong enhancers of the small intestine may reduce the bioavailability of diazepam

diclofenac (systemic)

CYP2C9 enhancers may decrease the the bioavailability of diclofenac (systemic)

diltiazem

CYP3A strong enhancers of the small intestine may reduce the bioavailability of diltiazem 

disopyramide

CYP3A strong enhancers of the small intestine may reduce the bioavailability of disopyramide

domperidone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of domperidone 

doravirine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of doravirine

doxercalciferol

CYP3A enhancers (strong) may increase plasma concentrations of the active metabolite(s) of doxercalciferol

doxorubicin (conventional)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of doxorubicin (conventional)

dronabinol

CYP3A strong enhancers of the small intestine may reduce the bioavailability of dronabinol 

dronedarone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of dronedarone

duvelisib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of duvelisib

dydrogesterone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of dydrogesterone

ebastine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ebastine

efavirenz

CYP3A strong enhancers of the small intestine may reduce the bioavailability of efavirenz

elagolix

CYP3A strong enhancers of the small intestine may reduce the bioavailability of elagolix

elbasvir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of elbasvir

elexacaftor

CYP3A strong enhancers of the small intestine may reduce the bioavailability of elexacaftor

eliglustat

CYP3A strong enhancers of the small intestine may reduce the bioavailability of eliglustat 

elvitegravir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of elvitegravir

encorafenib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of encorafenib

enfortumab vedotin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of enfortumab vedotin

entrectinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of entrectinib

eplerenone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of eplerenone

eravacycline

CYP3A strong enhancers of the small intestine may reduce the bioavailability of eravacycline 

erdafitinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of erdafitinib

erlotinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of erlotinib

escitalopram

CYP3A strong enhancers of the small intestine may reduce the bioavailability of escitalopram 

estazolam

CYP3A strong enhancers of the small intestine may reduce the bioavailability of estazolam 

eszopiclone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of eszopiclone 

ethosuximide

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ethosuximide

etizolam

CYP3A strong enhancers of the small intestine may reduce the bioavailability of etizolam

etoposide

CYP3A strong enhancers of the small intestine may reduce the bioavailability of etoposide

etoposide phosphate

CYP3A strong enhancers of the small intestine may reduce the bioavailability of etoposide phosphate

etoricoxib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of etoricoxib

etravirine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of etravirine

everolimus

CYP3A strong enhancers of the small intestine may reduce the bioavailability of everolimus

evogliptin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of evogliptin

exemestane

CYP3A strong enhancers of the small intestine may reduce the bioavailability of exemestane

fedratinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of fedratinib

felbamate

CYP3A strong enhancers of the small intestine may reduce the bioavailability of felbamate

felodipine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of felodipine

fenfluramine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of fenfluramine

fentanyl

CYP3A strong enhancers of the small intestine may reduce the bioavailability of fentanyl 

fexinidazole

CYP3A enhancers may enhance plasma concentrations of the active metabolite(s) of fexinidazoleenzal

finerenone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of finerenone

flibanserin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of flibanserin 

fluvastatin

CYP2C9 enhancers may decrease the the bioavailability of fluvastatin 

fosaprepitant

CYP3A strong enhancers of the small intestine may reduce the bioavailability of fosaprepitant

fosphenytoin

phenytoin: enzalutamide may decrease the therapeutic efficacy of fosphenytoin-phenytoin

fostamatinib

CYP3A enhancers (strong) may reduce the plasma concentrations of the active metabolite(s) of fostamatinib 

fostemsavir

CYP3A enhancers (strong) may reduce the plasma concentrations of the active metabolite(s) of fostemsavir

gallium ga psma

antiandrogens may decrease the therapeutic effect of gallium ga 68 psma-11

ganaxolone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ganaxolone

gefitinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of gefitinib

gemigliptin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of gemigliptin

gilteritinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of gilteritinib 

glasdegib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of glasdegib

glecaprevir and pibrentasvir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of glecaprevir and pibrentasvir

guanfacine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of guanfacine

haloperidol

CYP3A strong enhancers of the small intestine may reduce the bioavailability of haloperidol

hormonal contraceptives

CYP3A strong enhancers of the small intestine may reduce the bioavailability of hormonal contraceptives

hydrocodone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of hydrocodone 

hydrocortisone (systemic)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of hydrocortisone (systemic)

ibrexafungerp

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ibrexafungerp  i

ibrutinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ibrutinib

idelalisib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of idelalisib

ifosfamide

CYP3A enhancers (strong) may increase plasma concentrations of the active metabolite(s) of ifosfamide enzal

imatinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of imatinib

indinavir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of indinavir

infigratinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of infigratinib

irinotecan products

CYP3A strong enhancers of the small intestine may reduce the bioavailability of irinotecan products

isavuconazonium sulfate

CYP3A strong enhancers may decrease the the bioavailability of isavuconazole  

isradipine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of isradipine

istradefylline

CYP3A strong enhancers of the small intestine may reduce the bioavailability of istradefylline

itraconazole

CYP3A strong enhancers of the small intestine may reduce the bioavailability of itraconazole

ivabradine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ivabradine 

ivacaftor

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ivacaftor 

ivosidenib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ivosidenib

ixabepilone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ixabepilone

ixazomib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ixazomib

ketamine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ketamine 

ketoconazole (systemic)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ketoconazole (systemic) 

lacidipine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of lacidipine

lapatinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of lapatinib

larotrectinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of larotrectinib

lefamulin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of lefamulin 

lefamulin (intravenous)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of lefamulin (intravenous)

lemborexant

CYP3A strong enhancers of the small intestine may reduce the bioavailability of lemborexant

lercanidipine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of lercanidipine

lesinurad

CYP2C9 enhancers may decrease the the bioavailability of lesinurad 

leuprolide and norethindrone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of leuprolide and norethindrone

levamlodipine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of levamlodipine

levoketoconazole

CYP3A strong enhancers of the small intestine may reduce the bioavailability of levoketoconazole 

levomethadone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of levomethadone 

levonorgestrel (iud)

CYP3A enhancers (strong) may diminish the therapeutic effect of levonorgestrel (iud) CYP3A strong enhancers of the small intestine may reduce the bioavailability of levonorgestrel (iud) 

lidocaine (systemic)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of lidocaine (systemic) 

linagliptin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of linagliptin

lonafarnib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of lonafarnib

lopinavir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of lopinavir

lorlatinib

CYP3A enhancers (strong) may enhance the hepatotoxic effect of lorlatinib CYP3A strong enhancers of the small intestine may reduce the bioavailability of lorlatinib

lornoxicam

CYP2C9 enhancers may decrease the the bioavailability of lornoxicam 

lumacaftor and ivacaftor

CYP3A strong enhancers of the small intestine may reduce the bioavailability of lumacaftor and ivacaftor

lumateperone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of lumateperone

lurasidone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of lurasidone 

lurbinectedin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of lurbinectedin 

macimorelin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of macimorelin

macitentan

CYP3A strong enhancers of the small intestine may reduce the bioavailability of macitentan 

manidipine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of manidipine

maraviroc

CYP3A strong enhancers of the small intestine may reduce the bioavailability of maraviroc

maribavir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of maribavir 

mavacamten

CYP3A strong enhancers of the small intestine may reduce the bioavailability of mavacamten 

mefloquine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of mefloquine 

meperidine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of meperidine 

methadone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of methadone

methylergonovine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of methylergonovine

methylprednisolone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of methylprednisolone

mianserin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of mianserin 

midazolam

CYP3A strong enhancers of the small intestine may reduce the bioavailability of midazolam 

midostaurin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of midostaurin

mifepristone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of mifepristone 

mirabegron

CYP3A strong enhancers of the small intestine may reduce the bioavailability of mirabegron

mirodenafil

CYP3A strong enhancers of the small intestine may reduce the bioavailability of mirodenafil

mirtazapine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of mirtazapine 

mitapivat

CYP3A strong enhancers of the small intestine may reduce the bioavailability of mitapivat 

mobocertinib

mobocertinib: CYP3A enhancers (strong) may decrease plasma concentrations of the active metabolite(s) of mobocertinib and may reduce the bioavailability of mobocertinib 

naldemedine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of naldemedine  enzal

naloxegol

CYP3A strong enhancers of the small intestine may reduce the bioavailability of naloxegol 

nateglinide

CYP3A strong enhancers of the small intestine may reduce the bioavailability of nateglinide

nelfinavir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of nelfinavir 

neratinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of neratinib

netupitant

CYP3A strong enhancers of the small intestine may reduce the bioavailability of netupitant 

nevirapine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of nevirapine

nicardipine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of nicardipine 

nifedipine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of nifedipine management: avoid coadministration of nifedipine with strong CYP3A enhancers when possible and if combined, monitor patients closely for clinical signs of diminished nifedipine response 

nilotinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of nilotinib

nilvadipine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of nilvadipine 

nimodipine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of nimodipine 

nintedanib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of nintedanib 

nirmatrelvir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of nirmatrelvir 

nisoldipine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of nisoldipine

nitrendipine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of nitrendipine

olaparib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of olaparib

oliceridine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of oliceridine 

olmutinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of olmutinib 

omeprazole

CYP2C19 enhancers (moderate) may reduce the therapeutic efficacy of omeprazole 

ondansetron

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ondansetron

osilodrostat

CYP3A strong enhancers of the small intestine may reduce the bioavailability of osilodrostat

osimertinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of osimertinib

ospemifene

enzalutamide may reduce the therapeutic efficacy of ospemifene 

oxcarbazepine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of oxcarbazepine

oxycodone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of oxycodone

paclitaxel (conventional)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of paclitaxel (conventional) 

paclitaxel (protein bound)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of paclitaxel (protein bound) 

pacritinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of pacritinib 

palbociclib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of palbociclib

panobinostat

CYP3A strong enhancers of the small intestine may reduce the bioavailability of panobinostat 

pazopanib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of pazopanib 

pemigatinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of pemigatinib 

perampanel

CYP3A strong enhancers of the small intestine may reduce the bioavailability of perampanel 

pexidartinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of pexidartinib 

pimavanserin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of pimavanserin 

piperaquine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of piperaquine

pitolisant

CYP3A strong enhancers of the small intestine may reduce the bioavailability of pitolisant 

polatuzumab vedotin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of polatuzumab vedotin 

ponatinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ponatinib

pralsetinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of pralsetinib

praziquantel

CYP3A strong enhancers of the small intestine may reduce the bioavailability of praziquantel 

prednisolone (systemic)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of prednisolone (systemic) 

prednisone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of prednisone 

pretomanid

CYP3A strong enhancers of the small intestine may reduce the bioavailability of pretomanid 

propafenone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of propafenone 

quetiapine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of quetiapine 

quinidine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of quinidine

quinine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of quinine 

radotinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of radotinib

ramelteon

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ramelteon 

ranolazine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ranolazine 

reboxetine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of reboxetine

regorafenib

CYP3A enhancers (strong) may increase plasma concentrations of the active metabolite(s) of regorafenib and it may reduce the bioavailability of regorafenib

remdesivir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of remdesivir

repaglinide

CYP3A strong enhancers of the small intestine may reduce the bioavailability of repaglinide 

ribociclib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ribociclib

rifabutin

may reduce the therapeutic efficacy of enzalutamide

rifapentine

may reduce the therapeutic efficacy of enzalutamide

rilpivirine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of rilpivirine 

rimegepant

CYP3A strong enhancers of the small intestine may reduce the bioavailability of rimegepant

riociguat

CYP3A strong enhancers of the small intestine may reduce the bioavailability of riociguat

ripretinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ripretinib 

risperidone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of risperidone

ritonavir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ritonavir

rivaroxaban

CYP3A strong enhancers of the small intestine may reduce the bioavailability of rivaroxaban

roflumilast

CYP3A strong enhancers of the small intestine may reduce the bioavailability of roflumilast

rolapitant

CYP3A strong enhancers of the small intestine may reduce the bioavailability of rolapitant 

romidepsin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of romidepsin

ruxolitinib (systemic)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ruxolitinib (systemic)

samidorphan

CYP3A strong enhancers of the small intestine may reduce the bioavailability of samidorphan 

saquinavir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of saquinavir management: consider alternatives to strong CYP3A enhancers in patients treated with saquinavir if combined, monitor closely for signs of decreased saquinavir concentrations and effects 

saxagliptin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of saxagliptin

selpercatinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of selpercatinib

selumetinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of selumetinib

sertindole

CYP3A strong enhancers of the small intestine may reduce the bioavailability of sertindole

sertraline

CYP3A strong enhancers of the small intestine may reduce the bioavailability of sertraline

sildenafil

CYP3A strong enhancers of the small intestine may reduce the bioavailability of sildenafil

simeprevir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of simeprevir

siponimod

enzalutamide may reduce the therapeutic efficacy of siponimod 

sirolimus (conventional)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of sirolimus (conventional)

sirolimus (protein bound)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of sirolimus (protein bound)

solifenacin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of solifenacin 

sonidegib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of sonidegib 

sorafenib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of sorafenib

sotorasib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of sotorasib

stiripentol

CYP3A strong enhancers of the small intestine may reduce the bioavailability of stiripentol 

sufentanil

CYP3A strong enhancers of the small intestine may reduce the bioavailability of sufentanil

sulfonylureas

CYP2C9 enhancers may decrease the the bioavailability of sulfonylureas 

sunitinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of sunitinib

suvorexant

CYP3A strong enhancers of the small intestine may reduce the bioavailability of suvorexant 

tacrolimus (systemic)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of tacrolimus (systemic)

tadalafil

CYP3A strong enhancers of the small intestine may reduce the bioavailability of tadalafil

tamoxifen

CYP3A strong enhancers of the small intestine may reduce the bioavailability of tamoxifen 

tasimelteon

CYP3A strong enhancers of the small intestine may reduce the bioavailability of tasimelteon 

tazemetostat

CYP3A strong enhancers of the small intestine may reduce the bioavailability of tazemetostat 

telithromycin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of telithromycin

temsirolimus

CYP3A enhancers (strong) may decrease plasma concentrations of the active metabolite(s) of temsirolimus

teniposide

CYP3A strong enhancers of the small intestine may reduce the bioavailability of teniposide

tepotinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of tepotinib

tetrahydrocannabinol

CYP3A strong enhancers of the small intestine may reduce the bioavailability of tetrahydrocannabinol  tetrahydrocannabinol and cannabidiol: CYP3A strong enhancers of the small intestine may reduce the bioavailability of tetrahydrocannabinol and cannabidiol  

tezacaftor and ivacaftor

CYP3A strong enhancers of the small intestine may reduce the bioavailability of tezacaftor and ivacaftor

thiotepa

CYP3A enhancers (strong) may increase plasma concentrations of the active metabolite(s) of thiotepa and reduce the the bioavailability of thiotepa 

tiagabine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of tiagabine

ticagrelor

CYP3A enhancers (strong) may decrease plasma concentrations of the active metabolite(s) of ticagrelor

tipranavir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of tipranavir

tivozanib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of tivozanib

tofacitinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of tofacitinib 

tolvaptan

CYP3A strong enhancers of the small intestine may reduce the bioavailability of tolvaptan

toremifene

CYP3A enhancers (strong) may decrease plasma concentrations of the active metabolite(s) of toremifene

torsemide

CYP2C9 enhancers may decrease the the bioavailability of torsemide 

trabectedin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of trabectedin

tramadol

CYP3A strong enhancers of the small intestine may reduce the bioavailability of tramadol 

trazodone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of trazodone 

triamcinolone (systemic)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of triamcinolone (systemic) 

triazolam

CYP3A strong enhancers of the small intestine may reduce the bioavailability of triazolam 

tropisetron

CYP3A strong enhancers of the small intestine may reduce the bioavailability of tropisetron 

tucatinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of tucatinib

ubrogepant

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ubrogepant 

udenafil

CYP3A strong enhancers of the small intestine may reduce the bioavailability of udenafil 

ulipristal

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ulipristal 

upadacitinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of upadacitinib 

vandetanib

CYP3A enhancers (strong) may increase plasma concentrations of the active metabolite(s) of vandetanib and reduce the the bioavailability 

velpatasvir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of velpatasvir 

vemurafenib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of vemurafenib 

venetoclax

CYP3A strong enhancers of the small intestine may reduce the bioavailability of venetoclax 

verapamil

CYP3A strong enhancers of the small intestine may reduce the bioavailability of verapamil 

vilazodone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of vilazodone 

vincristine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of vincristine 

vincristine (liposomal)

CYP3A strong enhancers of the small intestine may reduce the bioavailability of vincristine (liposomal) 

vinflunine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of vinflunine

vinorelbine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of vinorelbine 

vitamin k antagonists (eg warfarin)

enzalutamide may reduce the therapeutic efficacy of vitamin k antagonists 

voclosporin

CYP3A strong enhancers of the small intestine may reduce the bioavailability of voclosporin

vonoprazan

CYP3A strong enhancers of the small intestine may reduce the bioavailability of vonoprazan 

vorapaxar

CYP3A strong enhancers of the small intestine may reduce the bioavailability of vorapaxar 

voriconazole

CYP3A strong enhancers of the small intestine may reduce the bioavailability of voriconazole

vortioxetine

CYP3A strong enhancers of the small intestine may reduce the bioavailability of vortioxetine

voxelotor

CYP3A strong enhancers of the small intestine may reduce the bioavailability of voxelotor

voxilaprevir

CYP3A strong enhancers of the small intestine may reduce the bioavailability of voxilaprevir 

zaleplon

CYP3A strong enhancers of the small intestine may reduce the bioavailability of zaleplon 

zanubrutinib

CYP3A strong enhancers of the small intestine may reduce the bioavailability of zanubrutinib 

ziprasidone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of ziprasidone 

zolpidem

CYP3A strong enhancers of the small intestine may reduce the bioavailability of zolpidem 

zonisamide

CYP3A strong enhancers of the small intestine may reduce the bioavailability of zonisamide 

zopiclone

CYP3A strong enhancers of the small intestine may reduce the bioavailability of zopiclone 

zuclopenthixol

CYP3A strong enhancers of the small intestine may reduce the bioavailability of zuclopenthixol

alpelisib

when both drugs are combined, there may be a decreased level of serum concentration of alpelisib   

lorlatinib

the effect of enzalutamide is decreased by lorlatinib, by altering intestinal or hepatic CYP3A4 enzyme metabolism

ixazomib

enzalutamide decreases the effect of ixazomib by altering intestinal/hepatic CYP3A4 enzyme metabolism

lapatinib

enzalutamide decreases the effect of lapatinib by altering the intestinal or hepatic CYP3A4 enzyme metabolism

fedratinib

enzalutamide decreases the effect of fedratinib by altering the intestinal/hepatic CYP3A4 enzyme metabolism

palbociclib

it decreases the effect or level of palbociclib by altering the intestinal or hepatic CYP3A4 enzyme metabolism

ethotoin

may increase the level by affecting hepatic enzyme CYP3A4 metabolism

primidone

may increase the level by affecting hepatic enzyme CYP3A4 metabolism

nitrazepam

may increase the level by affecting hepatic enzyme CYP3A4 metabolism

paramethadione

may increase the level by affecting hepatic enzyme CYP3A4 metabolism

flotufolastat F18 

It may diminish its effectiveness when combined with flotufolastat F-18

oleandomycin 

When enzalutamide is used together with oleandomycin, this leads to enhanced concentration serum of enzalutamide

ridaforolimus 

When enzalutamide is used together with ridaforolimus, this leads to enhanced concentration serum of enzalutamide

sulfanilamide 

the serum concentration of enzalutamide can be raised when it is combined with sulfanilamide

topotecan

when both drugs are combined, there may be a reduced excretion rate of topotecan and result in a high level of serum concentration  

brentuximab

has an antagonistic effect over brentuximab vedotin, by showing altered intestinal/hepatic CYP3A4 enzyme metabolism.

ospemifene 

may diminish the serum concentration

tocofersolan 

the serum levels of tocofersolan may be reduced with enzalutamide

 

Dosage forms & Strengths 

Capsule, Oral:  

40 mg  

Tablet, Oral: 

40 mg 

80 mg  

Note: Patients under enzalutamide therapy should also be accompanied by a gonadotropin-releasing hormone analog concurrently  

Carcinoma Of Prostate

Metastatic:

160

mg

orally

once a day



Dose Adjustments

  • For grade 3 to grade 2 toxicity: Discontinue the treatment, intolerable side effects occur
    Resume the dose with 75% (120 mg orally once a day), if symptoms improve
  • Serious hypersensitivity reactions: Permanently discontinue the treatment
  • Grade 3 or 4, ischemic heart disease: discontinue the treatment
  • Posterior reversible encephalopathy, Seizures: Permanently discontinue the treatment
  •  

    No safe dosing is established 




     

    Refer to adult dosing 




    Frequency defined: 

    >10%: 

    Hypertension (14%) 

    Peripheral edema (15%) 

    Decreased appetite 

    Hypermagnesemia 

    Weight loss (12%) 

    Decreased white blood cells  

    Diarrhea 

    Nausea 

    Dizziness 

    Fatigue 

    Headache 

    Muscle pain 

    Dyspnea 

    Back pain  

    1% to 10% 

    Cardiac arrhythmia (3%) 

    Pruritis 

    Bone fracture 

    Anxiety 

    Cognitive dysfunction 

    Insomnia 

    Restless leg 

    Hematuria 

    Muscle rigidity  

    <1% 

    Tongue edema 

    Seizure 

    Facial edema  

    Frequency not defined: 

    Hypersensitivity reaction 

     

    Pregnancy consideration: No data available regarding pregnancy effects of enzalutamide. 

    Lactation: excretion of enzalutamide in breast milk is unknown. 

    Pregnancy category: 

    • Category A: Satisfactory and well-controlled studies show no evidence of risk to the fetus in the first trimester or the later trimester. 
    • Category B: There is no evidence of risk to the fetus found in animal reproduction studies and there are not enough studies on pregnant women. 
    • Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for an effect in humans, care must be taken for potential risks in pregnant women 
    • Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite potential risks may be used only in emergency cases for potential benefits. 
    • Category X: Drugs listed in this category outweigh risks over benefits These category drugs should be prohibited for pregnant women. 
    • Category N: There is no data available for the drug under this category. 

    Patient information leaflet 

    Generic Name: Enzalutamide 

    Pronounced: enza-lu-ta-myd 

     

    Why do we use enzalutamide? 

    Enzalutamide is an antiandrogen class of antineoplastic drug. It is used to treat prostate cancer. 

    ADVERTISEMENT 

    enzalutamide

    Brand Name :

    Xtandi

    Synonyms :

    Class :

    Antineoplastic agents & Antiandrogens




    No data available for drug.

    Dosage forms & Strengths 

    Capsule, Oral:  

    40 mg  

    Tablet, Oral: 

    40 mg 

    80 mg  

    Note: Patients under enzalutamide therapy should also be accompanied by a gonadotropin-releasing hormone analog concurrently  

    Carcinoma Of Prostate

    Metastatic:

    160

    mg

    orally

    once a day



    Dose Adjustments

  • For grade 3 to grade 2 toxicity: Discontinue the treatment, intolerable side effects occur
    Resume the dose with 75% (120 mg orally once a day), if symptoms improve
  • Serious hypersensitivity reactions: Permanently discontinue the treatment
  • Grade 3 or 4, ischemic heart disease: discontinue the treatment
  • Posterior reversible encephalopathy, Seizures: Permanently discontinue the treatment
  • No safe dosing is established 




    Refer to adult dosing 




    DRUG INTERACTION

    enzalutamide

    &

    • ibandronic acid
    • cinnarizine and dimenhydrinate
    • ursodeoxycholic acid
    • rhubarb extract/salicylic acid
    • butamirate citrate
    • fumitory
    • taheebo
    • uva ursi
    • vervain
    • coleus
    • coltsfoot
    • crampbark
    • plantain
    • potassium nitrate and silver nitrate
    • gelsemium
    • gentian
    • glucomannan
    • walnut
    • meadowsweet
    • midomafetamine
    • pennyroyal
    • periwinkle
    • betony
    • bitter orange
    • bladderwrack
    • bloodroot
    • emu oil
    • garcinia
    • yellow dock
    • burdock
    • dehydroepiandrosterone
    • aucubin
    • jasmone
    • resacetophenone
    • ecamsule ditriethanolamine
    • feclobuzone
    • fenoprop triethanolamine
    • verdyl acetate
    • caffeic acid
    • cyclamen aldehyde
    • dicetyldimonium chloride
    • wogonin
    • impacarzine
    • laurylpyridinium chloride
    • stepronin
    • matrine
    • sakuranin
    • cannabichromene
    • sandalore
    • sabinene
    • oxypaeoniflora
    • ethylhexyl pelargonate
    • acrylonitrile
    • allyl alcohol
    • dipalmitoylethyl hydroxyethylmonium methosulfate
    • butidrine
    • clothiapine
    • propanediol dicaprylate
    • buchu
    • undecanol
    • enilconazole
    • xymenynic acid
    • angelica
    • nizubaglustat
    • resomelagon
    • ulecaciclib
    • apple cider vinegar
    • bacopa
    • barley grass
    • dandelion
    • deer velvet
    • dolomite
    • bugleweed
    • bupleurum
    • glyceryltrinitrate
    • pociredir
    • asnuciclib
    • actalycabtagene autoleucel
    • butantan–dengue vaccine
    • travoprost/timolol
    • furosemide/potassium chloride
    • amylamine
    • jaborandi
    • patritumab deruxtecan
    • jackfruit
    • sterculia
    • ascorbigen
    • ashitaba
    • androstenetrione
    • andrachne
    • cosibelimab
    • racecadotril
    • neomycin/chlorhexidine
    • octocog alfa
    • cetrimide
    • ispaghula husk
    • polyhexanide
    • octenidine
    • polygeline
    • heparinoid
    • jewelweed
    • boldo
    • anizatrectinib
    • alpinia
    • henbane
    • cynanchum vincetoxicum root and sulfur
    • boditrectinib
    • izumerogant
    • zavondemstat
    • abuta
    • fadogia agrestis
    • fly agaric mushroom
    • meptazinol
    • methoxyflurane
    • tramadol/dexketoprofen
    • betaine/polyhexanide
    • filgotinib
    • inosine acedoben dimepranol
    • alverine citrate
    • hyoscine butylbromide
    • senna+ ispaghula
    • cabbage palm
    • cajeput oil
    • calanus oil
    • calamint
    • canada balsam
    • carnosine
    • alverine citrate/simeticone
    • dihydroartemisinin/piperaquine
    • mebeverine/ispaghula
    • calcipotriol
    • tacalcitol
    • triethyl citrate/ethyl linoleate
    • sodium dilauramidoglutamide lysine
    • fazamorexant
    • avibactam tomilopil and ceftibuten
    • drostanolone
    • tigilanol tiglate
    • isorhynchophylline
    • rhynchophylline
    • crisugabalin
    • epigallocatechin gallate
    • clomocycline
    • corynoxeine
    • isocorynoxeine
    • Culmerciclib
    • Neladenoson
    • ambrein
    • hexylcaine
    • phensuximide
    • resencatinib (investigational)
    • rolusafine
    • pumecitinib
    • arhalofenic acid
    • berdazimer sodium
    • benzquinamide
    • clidinium
    • sulfametopyrazine
    • fulzerasib (Investigational Drug)
    • rovadicitinib (Investigational Drug)
    • Upleganan (Investigational Drug)
    • menthyl ethylamido oxalate
    • quaternium-90 montmorillonite
    • unecritinib (investigational drug)
    • etohexadiol
    • guaiol
    • proximadiol
    • verdinexor
    • sofnobrutinib
    • talbutal
    • ethoxzolamide
    • propiomazine
    • enprofylline
    • phenmetrazine
    • merigolix
    • pralurbactam
    • neracorvir
    • vonifimod
    • apaziquone hydroquinone
    • darizmetinib
    • zandelisib
    • xininurad
    • ritivixibat
    • amiselimod phosphate (investigational drug)
    • emzeltrectinib (investigational drug)
    • ficonalkib
    • cinalukast
    • ulobetasol
    • candoxatril
    • nitrofural
    • acetyldigitoxin
    • bentiromide
    • dextrothyroxine
    • chlorotrianisene
    • remikiren
    • pipobroman
    • vidarabine
    • immune globulin intravenous, human-stwk
    • spermine
    • serine
    • N-acetyl glucosamine
    • valine
    • adenine
    • asparagine
    • citrulline
    • adinazolam
    • interferon alfacon-1
    • interferon alfa-n1
    • felypressin
    • birch triterpenes
    • pyridoxal phosphate
    • technetium Tc-99m arcitumomab
    • beta-alanine
    • dihomo-gamma-linolenic acid
    • urea/hydrocortisone
    • R21/Matrix-M vaccine
    • povidone-iodine (ophthalmic)
    • pheniramine
    • hydrocortisone rectal
    • chloroxylenol/pramoxine/zinc acetate
    • chloroxylenol/pramoxine
    • dextrose/sucrose/vitamin C/zinc sulphate
    • furazolidone/metronidazole/dicyclomine
    • ergocalciferol (vitamin D2)
    • benoxaprofen (discontinued)
    • teicoplanin
    • carbomer
    • chromic chloride / iron (ii) chloride tetrahydrate / potassium iodide / manganese chloride / sodium fluoride / sodium selenite pentahydrate / sodium molybdate dihydrate / zinc chloride/ cupric chloride
    • bufylline
    • lidocaine/prilocaine
    • opium tincture, squill oxymel
    • dibrompropamidine
    • metronidazole/tetracycline/bismuth subsalicylate
    • agnus- castus
    • velaglucerase alfa
    • alendronic acid / colecalciferol
    • bimatoprost / timolol
    • efbemalenograstim alfa
    • dried ferrous sulfate/folic acid
    • dried ferrous sulfate / sodium ascorbate
    • nirogacestat
    • soya-bean oil, medium-chain triglycerides
    • demeclocycline hydrochloride and triamcinolone acetonide
    • fusidic acid / hydrocortisone acetate
    • macrogol
    • storax, benzoin
    • nomegestrol acetate/estradiol
    • flumetasone pivalate/ clioquinol
    • berdazimer topical (Pending FDA Approval)
    • buflomedil
    • butobarbital
    • andexanet alfa
    • methoxypolyethylene glycol-epoetin beta
    • viscum abietis
    • pramoxine vaginal
    • bupivacaine implant
    • cromolyn sodium, inhaled
    • pneumococcal vaccine 20-valent
    • bimatoprost ophthalmic implant
    • tick-borne encephalitis vaccine
    • chloroprocaine ophthalmic
    • travoprost intraocular implant (Pending FDA approval)
    • typhoid polysaccharide vaccine
    • sodium phosphate rectal
    • human papillomavirus vaccine, nonavalent
    • peanut immunotherapy epicutaneous (FDA approval pending)
    • cromolyn sodium, intranasal
    • red blood cells(Blood component)
    • oral mucoadhesive
    • clindamycin vaginal
    • whole blood (Blood Component)
    • fibrinogen/thrombin
    • levothyroxine/liothyronine
    • ipratropium intranasal
    • metronidazole vaginal
    • cyamemazine
    • brinase
    • reviparin
    • ulinastatin
    • saruplase
    • acepromazine
    • emylcamate
    • methionine
    • amino acids and electrolytes in dextrose with calcium
    • slippery elm
    • camostat
    • hemoglobin crosfumaril
    • moperone
    • chlormidazole
    • brilaroxazine
    • palopegteriparatide
    • diazepam buccal
    • benegrastim (pending for FDA approval)
    • COVID-19 vaccine, adjuvanted-Novavax
    • vestronidase alfa-vjbk
    • tebipenem (Pending FDA Approval)
    • tislelizumab (Pending FDA Approval)
    • zolbetuximab (Pending FDA Approval)
    • zoliflodacin (pending FDA approval)
    • zibotentan and dapagliflozin
    • fluorine F18 DCFPyL
    • debamestrocel
    • givinostat
    • amubarvimab and romlusevimab(Pending FDA Approval)
    • sabizabulin(Pending FDA approval)
    • fexapotide(Phase 3 Clinical trial)
    • diatrizoic acid
    • drotaverine
    • diethyl phthalate
    • enclomiphene
    • epalrestat
    • ethamsylate
    • flupirtine
    • imidurea
    • sodium glycolate
    • feracrylum
    • ethacridine
    • furazolidone/metronidazole
    • ozagrel hydrochloride
    • leptazol
    • l-glutamic acid /vitamin B complex
    • etizolam
    • etizolam/propranolol
    • ethoheptazine citrate
    • etophylline and theophylline
    • etophylline
    • finger millet
    • drotaverine/mefenamic acid
    • dichloroxylenol
    • pneumococcal 7-valent vaccine
    • diclofenac and metaxalone
    • dipivefrin ophthalmic
    • enbucrilate
    • potassium citrate and citric acid
    • potassium gluconate
    • aclarubicin
    • alfuzosin/dutasteride
    • adrenochrome monosemicarbazone
    • selenium sulfide topical
    • sertaconazole
    • amorolfine cream
    • amsacrine
    • amylmetacresol
    • sulfonated phenolics in aqueous solution
    • technetium Tc-99m sulfur colloid
    • raltitrexed
    • romiplostim
    • acediasulfone
    • azulene
    • acebrophylline
    • clonazepam/escitalopram oxalate
    • allylestrenol
    • andrographolide
    • artemotil
    • technetium Tc-99m sestamibi
    • rubidium Rb-82
    • somapacitan
    • sodium sulfate, magnesium sulfate and potassium sulfate
    • almitrine
    • gramicidin
    • nikethamide
    • technetium Tc-99m sodium pertechnetate
    • betiatide
    • prilocaine/epinephrine
    • amlexanox
    • acetaminophen/salicylamide/phenyltoloxamine
    • neomycin topical
    • zilucoplan
    • antazoline and xylometazoline
    • toripalimab
    • iron isomaltoside
    • meningococcal A C Y and W polysaccharide tetanus toxoid conjugate vaccine
    • meningococcal A C Y and W-135 diphtheria conjugate vaccine
    • tetradecyl Sulfuric Acid
    • benzoyl peroxide, clindamycin phosphate, adapalene
    • ethylephedrine
    • actarit
    • pyrantel tartrate
    • tenofovir disoproxil fumarate or tenofovir DF
    • melitracen
    • amitriptylinoxide(Phase 4 Clinical Trials)
    • threonine
    • ditiocarb zinc
    • epicriptine
    • levallorphan
    • kinetin
    • laurocapram
    • pentagastrin
    • parthenolide
    • nicoboxil
    • protionamide
    • prulifloxacin
    • proscillaridin
    • tizanidine and rofecoxib
    • tolnaftate, gentamicin, chinoform and betamethasone valerate
    • pine bark extract
    • pipenzolate methylbromide
    • bephenium hydroxynaphthoate
    • niclosamide
    • pyrvinium
    • pipenzolate methylbromide/phenobarbitone
    • piracetam/ginkgo biloba/vinpocetine
    • benzyl benzoate/disulfiram
    • benzyl benzoate
    • loperamide/simethicone
    • piroctone olamine
    • sodium fusidate
    • piroxicam topical/capsaicin/menthol/methyl salicylate
    • sodium metabisulfite
    • sodium lauryl sulfate
    • taspoglutide
    • glyclopyramide
    • tolnaftate, gentamicin, iodochlorohydroxyquinoline, chlorocresol, betamethasone valerate
    • serratiopeptidase
    • sodium antimony gluconate
    • triamterene / benzthiazide
    • tribenoside / lidocaine
    • triclocarban
    • triprolidine/dextromethorphan  
    • vitamins/minerals/omega-3 Fatty acids
    • soyabean oil
    • sucralfate/oxethazaine
    • sucralfate/tinidazole/povidone iodine
    • sodium cromoglycate
    • aloe vera/liquid paraffin/white soft paraffin
    • aloe vera/jojoba oil/vitamin E
    • allantoin/triclosan/vitamin e/zinc oxide
    • alpha-Lipoic acid/minerals/multivitamins
    • alprazolam/paracetamol
    • alprazolam/melatonin
    • azithromycin/ambroxol
    • atorvastatin/clopidogrel/aspirin
    • aceclofenac, paracetamol and serratiopeptidase
    • alfacalcidol, vitamin B-complex, minerals and antioxidants
    • alpha- lipoic acid, vitamin b complex and vitamin c
    • alpha-galactosidase and simethicone
    • alpha-galactosidase, amylase, proteases, lipase and lactase
    • amikacin and cefepime
    • aminophylline, ephedrine and phenobarbitone
    • artesunate, sulphadoxine and pyrimethamine
    • finasteride/tamsulosin
    • flavoxate/ofloxacin
    • fenofibrate/metformin
    • lignocaine, hydrocortisone topical and allantoin
    • linoleic acid and sodium lactate
    • troxerutin
    • meclizine/nicotinic acid
    • mecobalamin/ginkgo Biloba
    • spirulina
    • loperamide and furazolidone
    • ketoconazole/cetrimide
    • ketoconazole/zinc pyrithione
    • lercanidipine/atenolol
    • levocetirizine/montelukast/ambroxol
    • levarterenol
    • levocetirizine/phenylpropanolamine 
    • indapamide/amlodipine
    • itopride/methyl polysiloxane
    • mebendazole/levamisole
    • eberconazole/mometasone
    • gliclazide/metformin/pioglitazone
    • fluconazole/tinidazole
    • haemocoagulase
    • halometasone
    • hesperidin
    • imipramine/chlordiazepoxide
    • idebenone / l-arginine / zinc sulphate/selenium/proanthocyanidin
    • mecobalamin and piracetam
    • mesterolone
    • mosapride and pantoprazole
    • atorvastatin, co enzyme q10, vitamin e, zinc, and selenium
    • azithromycin and benzalkonium chloride
    • beta carotene, vitamin c, vitamin e, minerals, lutein, eicosapentaenoic acid, docosahexenoic acid and vit b12
    • alpha-galactosidase
    • aloe vera gel/vitamin e/lactic acid
    • aloe vera gel/jojoba/vitamin e/glycerine
    • famotidine and domperidone
    • faropenem medoxomil
    • nedosiran
    • fluconazole/ornidazole/azithromycin
    • ebastine/montelukast
    • eberconazole
    • dienogest/estradiol valerate
    • ambroxol/salbutamol
    • benzoic acid/salicylic acid/ichthammol/ triamcinolone acetonide
    • desloratadine/ambroxol
    • dexibuprofen/paracetamol
    • atorvastatin/ramipril
    • diastase
    • diastase and simethicone
    • diazepam and propranolol
    • dexrabeprazole / domperidone
    • dexrabeprazole
    • dexketoprofen /paracetamol
    • beta carotene/vitamin C/minerals
    • aloe vera gel/urea
    • aloe vera gel/glycerine
    • alpha-lipoic acid/benfotiamine/chromium/folic acid/mecobalamin / vit b6
    • alprazolam/propranolol
    • alprazolam /sertraline
    • ibuprofen/dextropropoxyphene
    • ambroxol/cetirizine/phenylephrine/ guaiphenesin/menthol
    • dextropropoxyphene/dexchlorpheniramine maleate/bromhexine
    • promegestone
    • batroxobin
    • bencyclane
    • benfluorex
    • acetylpheneturide
    • abarelix
    • abetimus
    • naftidrofuryl
    • nalorphine
    • oxiracetam
    • letosteine
    • lafutidine
    • leuprorelin
    • levodropropizine
    • glutaral
    • losartan/ramipril
    • gallopamil
    • lanatoside c
    • lauromacrogol
    • gestodene
    • aceclofenac/methyl salicylate/menthol/linseed oil/capsaicin
    • aceclofenac/paracetamol/tizanidine
    • alginic acid/magaldrate/simethicone
    • aceclofenac/paracetamol
    • aceclofenac/rabeprazole
    • alginic acid
    • pantoprazole and domperidone
    • urokinase
    • rimiterol
    • olanzapine/fluoxetine
    • normethadone/hydroxyephedrine
    • myrtol
    • moxonidine
    • propylhexedrine
    • sodium hypochlorite solution
    • sodium chloride/sodium citrate
    • Hepatitis B Vaccine (Recombinant [Adjuvanted])
    • Hepatitis B Vaccine (Recombinant)
    • aceclofenac and serratiopeptidase
    • levosulpiride
    • niaprazine
    • tromantadine
    • trimetazidine
    • vinburnine
    • mizoribine
    • molgramostim
    • mosapride
    • eugenol
    • tolperisone
    • etamsylate
    • etynodiol
    • mizolastine
    • metenolone
    • reproterol
    • rebamipide
    • mephenoxalone
    • metandienone
    • furosemide/spironolactone
    • hydroxycarbamide
    • tenonitrozole
    • fenoverine
    • fenquizone
    • tiapride
    • tibolone
    • furazolidone
    • furosemide & amiloride
    • fosfestrol
    • fluclorolone
    • flubendazole
    • tertatolol
    • tetracosactide
    • tetryzoline
    • tolciclate
    • trapidil
    • troxipide
    • temoporfin
    • telbivudine
    • teprenone
    • hexamidine
    • mebhydrolin
    • mepartricin
    • fencamfamin
    • medazepam
    • theodrenaline
    • thiamazole
    • thiocolchicoside
    • psilocybin
    • veralipride
    • pyritinol
    • opipramol
    • oprelvekin
    • betamethasone + gentamicin
    • betamethasone + neomycin
    • betamethasone + salicylic acid
    • oxedrine
    • bopindolol
    • orgotein (investigational)
    • oxaceprol
    • ormeloxifene
    • bevantolol
    • bifemelane
    • clebopride
    • demoxytocin
    • cicletanine
    • cefsulodin
    • chlortalidon
    • sisomicin
    • somatrem
    • carbazochrome
    • caroverine
    • cathine
    • ipriflavone
    • isepamicin
    • silymarin
    • simethicone
    • sermorelin
    • diloxanide
    • dimethindene
    • diosmin/hesperidin
    • calamine
    • canrenone
    • captodiame
    • imidapril
    • cefetamet
    • cefodizime
    • cefoperazone + sulbactam
    • ivermectin + albendazole
    • serrapeptase
    • bromisoval
    • beraprost
    • pridinol
    • proglumide
    • bamipine
    • barnidipine
    • bamifylline
    • benzbromarone
    • betamethasone/fusidic acid
    • para-chlorophenol
    • pantethine
    • nomifensine
    • pemoline
    • parnaparin
    • pentolinium
    • nialamide
    • novobiocin
    • nicergoline
    • octocrylene
    • octisalate
    • oftasceine
    • oxolamine
    • oxyphencyclimine
    • penfluridol
    • pentoxyverine
    • phenoxymethylpenicillin
    • picloxydine
    • pilsicainide hydrochloride
    • piperazine
    • pirarubicin
    • policresulen
    • prifinium bromide
    • prethcamide
    • pristinamycin
    • pirenzepine
    • piribedil
    • pimethixene
    • pargyline
    • phosphatidyl choline
    • phthalylsulfathiazole
    • phytomenadione
    • pranlukast
    • pinazepam
    • oxyphenonium
    • noxytiolin
    • periciazine
    • pethidine
    • phenindamine
    • histidine
    • isoleucine
    • proline
    • lauric acid
    • lymecycline
    • hypromellose
    • abiraterone acetate and niraparib
    • ichthammol
    • levamisole
    • naftazone
    • nefopam
    • oxprenolol
    • oxybuprocaine
    • elranatamab-bcmm
    • lapyrium
    • isoaminile
    • iotrolan
    • mazindol
    • masoprocol
    • lypressin
    • meradimate
    • molsidomine
    • monobenzone
    • mequinol/gluconolactone/ lactobionic acid/ arbutin
    • medifoxamine
    • mebutamate
    • metergoline
    • methantheline
    • methdilazine
    • metocurine
    • micronomicin
    • metaraminol
    • mephenesin
    • menadione
    • medrysone
    • metixene
    • levobetaxolol
    • guaiacol glycerol ether
    • eucalyptol
    • sodium tetradecyl sulfate
    • sugammadex
    • carbetocin
    • certoparin
    • chlorcyclizine/pseudoephedrine
    • cephapirin
    • indecainide
    • iobitridol
    • iomeprol
    • chlorphenesin
    • msud analog
    • msud maxamum
    • iceland moss
    • glutethimide
    • hexachlorophene
    • haloprogin
    • deferoxamine
    • ethchlorvynol
    • dexpanthenol topical
    • etilefrine
    • deslanoside
    • carbocromen
    • diazolidinylurea
    • dibenzepin
    • etofamide
    • guanoxan
    • halazepam
    • guanadrel sulfate
    • dapiprazole
    • soapwort
    • debrisoquine
    • l-tryptophan
    • chlormerodrin
    • chlorquinaldol
    • cetrimonium
    • carbocisteine
    • chlorcyclizine/codeine
    • technetium Tc-99m tetrofosmin
    • technetium Tc-99m disofenin
    • technetium Tc-99m gluceptate
    • technetium Tc-99m labeled red blood cells
    • amylmetacresol/dextromethorphan hydrobromide
    • anileridine phosphate
    • pyrethrins
    • pyrantel pamoate
    • quinagolide
    • spiramycin
    • standard hyperkalemic cardioplegia solution
    • technetium tc-99m mertiatide
    • technetium tc-99m medronate
    • bemotrizinol / bisoctrizole
    • benfotiamine
    • bemotrizinol + titanium dioxide + zinc oxide
    • technetium Tc-99m oxidronate
    • technetium Tc-99m pentetate
    • technetium Tc-99m pyrophosphate
    • benziodarone
    • octinoxate/bisoctrizole
    • bicisate dihydrochloride
    • technetium Tc-99m bicisate
    • norelgestromin/ethinyl estradiol
    • norgestimate/ethinyl estradiol
    • ximelagatran (investigational)
    • xamoterol
    • trioxsalen
    • poly-urea urethane
    • rilmenidine
    • pemirolast
    • oxitriptan
    • beclomethasone, intranasal
    • thimerosal
    • camphor gel
    • camphor
    • mumps virus vaccine, live
    • rubella virus vaccine, live
    • aluminum chloride (dental)
    • alum irrigation
    • framycetin, phenylephrine, and gramicidin
    • ombitasvir, paritaprevir, ritonavir, and dasabuvir
    • olipudase alfa
    • etonogestrel/ethinyl estradiol
    • mycophenolate
    • fluoroestradiol F 18
    • donor organ cardioplegia solution
    • fluciclovine F 18
    • fusidic acid (ophthalmic)
    • fusidic acid and hydrocortisone
    • framycetin, dexamethasone, and gramicidin
    • fludeoxyglucose F-18
    • fluorouracil/salicylic acid
    • indium In-111 oxyquinoline
    • indium In-111 pentetreotide
    • indium In-111 capromab pendetide
    • lusutrombopag
    • mitomycin (ophthalmic)
    • mifepristone and misoprostol
    • minoxidil (systemic)
    • methyl aminolevulinate (topical)
    • methyl folate, methylcobalamin, and acetylcysteine
    • ciclesonide/formoterol/tiotropium
    • nedocromil (Oral Inhalation)
    • batefenterol (Investigational)
    • neostigmine and glycopyrrolate
    • nepafenac ophthalmic
    • netupitant/palonosetron
    • meperidine and promethazine
    • mepivacaine and levonordefrin
    • maltodextrin
    • medical cannabis
    • medium chain triglycerides
    • mometasone/glycopyrrolate (glycopyrronium)/ indacaterol
    • moxifloxacin ophthalmic
    • neomycin/fluocinolone
    • nadroparin
    • iodine I-125 iothalamate
    • amikacin liposome (oral inhalation)
    • bupivacaine liposome
    • natamycin
    • lopinavir and ritonavir
    • lysine
    • macitentan and tadalafil
    • mitomycin pyelocalyceal
    • moclobemide
    • mometasone and indacaterol
    • efinaconazole
    • blue-green algae
    • indocyanine green
    • follitropin beta
    • lumasiran
    • glycerin/lidocaine
    • edrophonium/atropine
    • indigo carmine
    • lutropin alfa
    • instant glucose/intravenous dextrose
    • iobenguane I-123
    • ixekizumab
    • isosulfan blue dye
    • levofloxacin ophthalmic
    • levonorgestrel oral/ferrous bisglycinate/ ethinylestradiol
    • ethinyl estradiol/levonorgestrel transdermal
    • hydroquinone
    • hydroxypropyl methylcellulose
    • icodextrin
    • lipid emulsion (soybean, medium-chain triglyceride, olive, and fish oils; [SMOF])
    • iodinated I 125 albumin
    • iodinated I 131 albumin
    • lipid emulsion (plant oil-based)
    • levonorgestrel intrauterine
    • levonorgestrel oral/ethinyl estradiol
    • lactic acid and sodium-PCA
    • lactated Ringer solution
    • ketotifen (systemic)
    • lanolin
    • leuprolide and norethindrone
    • levodopa and benserazide
    • gonadorelin acetate